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ABSTRACT 
Insulin resistance is a condition characterized by the inability of insulin to stimulate 
glucose uptake in skeletal muscle. This can lead to serious diseases such as metabolic 
syndrome, diabetes mellitus 2, cancer and blindness. The onset and progression of insulin 
resistance is correlated with a variety of environmental-related conditions, such as a high 
fat diet, chronic physical inactivity and sarcopenia, as well as physiological conditions 
such as obesity, hypercholesterolemia and chronic inflammation. It is clear that insulin 
resistance in skeletal muscle and the onset of Type 2 diabetes is correlated with a number 
of conditions that exhibit abnormal regulation of lipid metabolism, such as obesity and 
hypercholesterolemia. However, it still remains unclear if and how elevated circulating 
levels of cholesterol impact myofiber function at a cellular level, resulting in the 
inhibition of insulin signaling and glucose uptake. Mounting evidence suggests that 
accrual of cholesterol within skeletal muscle myofiber membranes may be causally 
linked to skeletal muscle insulin resistance and the onset of Type 2 diabetes. Cholesterol 
is found in both the external sarcolemma/T-tubule and internal sarcoplasmic reticulum 
membranes of skeletal myofibers. In the case of sarcolemma/T-tubule membranes, 
cholesterol-enriched micro-domains called caveolae contain insulin receptors and glucose 
transporter 4 (GLUT4) docking proteins. Cholesterol-rich caveolae are the site of GLUT4 
vesicle fusion with the sarcolemma/T-tubule membrane system during insulin-stimulated 
GLUT-4 mediated myofiber glucose uptake. Cholesterol is also found in sarcoplasmic 
reticulum membranes, a complex intra- membrane system from which GLUT-4 
containing membrane vesicles are derived. The sarcoplasmic reticulum is also the source 
and storage organelle for the intracellular calcium required for SNARE-mediated GLUT4 
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vesicle fusion with the external sarcolemma/T-tubule membrane which is the final step in 
insulin stimulated myofiber glucose uptake.  Evidence to suggest that overall myofiber 
membrane cholesterol content is an important regulator of insulin stimulated glucose 
uptake comes from in vivo and in vitro studies where increasing or decreasing myofiber 
membrane cholesterol content resulted in the inhibition or enhancement of insulin-
stimulated glucose uptake. Here we demonstrate a reliable and reproducible tissue culture 
model of skeletal myofibers consisting of highly differentiated C2C12 myotubes in which 
to mechanistically investigate the effects of selectively enriching or depleting the 
sarcolemma/T-tubule and/or sarcoplasmic reticulum membrane alone on insulin-
stimulated glucose uptake. Selective enrichment or depletion of C2C12 myotube 
membranes with native cholesterol was achieved by exposing differentiated C2C12 
myotubes to a methyl-β-cyclodextrin/cholesterol complex or methyl-β-cyclodextrin 
alone, utilizing specific pulse-chase labeling conditions in tissue culture. Confirmation 
that these defined pulse-chase labeling conditions selectively enriched or depleted 
specific myotube membranes was confirmed using a fluorescent analog of cholesterol, 
23-(dipyrrometheneboron-difluoride)-24-norcholesterol, which in turn was spatially 
resolved within myotube membranes using scanning confocal microscopy. The effects of 
selective cholesterol membrane enrichment in differentiated C2C12 myotubes on insulin-
stimulated glucose uptake were determined by measuring the uptake of 2-NBDG, a 
fluorescent analog of glucose. A 5x6-way ANOVA was used to determine any 
differences in insulin stimulated glucose uptake between membrane enrichment/depletion 
conditions across a range of insulin concentrations, while one-way ANOVAs were used 
to determine the effects of insulin concentration within each enrichment condition, as 
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well as any differences between enrichment conditions for particular insulin 
concentrations. Using this defined tissue culture model of insulin stimulated glucose 
uptake in skeletal muscle myotubes, we demonstrate that increased membrane cholesterol 
content is causally related to disruption of insulin receptor signaling and inhibition of 
insulin stimulated glucose uptake in C2C12 myotubes. We further demonstrate that this 
inhibition is greatest when the difference between the relative concentrations of 
cholesterol in the sarcolemma/T-tubule and the SR membranes is highest, rather than 
when the total cholesterol content of either membrane system is increased. Our findings 
provide direct experimental evidence that increased muscle membrane cholesterol 
content is causally related to inhibition of insulin signaling, insulin stimulated glucose 
uptake, and by extension GLUT4 translocation in skeletal muscle. These findings have 
significant physiological implications, especially as they relate to the underlying cellular 
mechanisms responsible for the development and onset of insulin resistance  
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Chapter 1 – Introduction 
Whole Body Glucose Homeostasis and the Importance of Skeletal Muscle 
 Skeletal muscle is responsible not only for the generation of force required for 
musculoskeletal movement but is also one of the most metabolically active tissues in the 
body. Representing up to 40% of total body mass in humans, skeletal muscle is a primary 
consumer of circulating glucose and is crucially important for maintaining whole body 
glucose homeostasis. Over and above the constitutive levels required to maintain basal 
cellular function, glucose uptake into skeletal muscle is stimulated by both the activation 
of the insulin signaling pathway in response to increased levels of glucose in the 
circulation, or by the increased metabolic needs of skeletal muscle during muscle 
contraction as a consequence of exercise or increased physical activity. As such, skeletal 
muscle tissue is critical in maintaining circulating levels of glucose within safe, normal 
levels within the body.   
Maintenance of circulating glucose levels are regulated by two major endocrine 
hormones: insulin and glucagon, both polypeptides produced within the pancreas. 
Glucagon is released into the circulation in response to decreased levels of circulating 
glucose and induces gluconeogenesis from glycogen stores in the liver. In contrast, 
insulin is released into the circulation in response to increased levels of circulating 
glucose and induces glucose uptake by target cells expressing the insulin receptor. In 
terms of whole body glucose homeostasis, it is the interplay between the actions of these 
two endocrine hormones and their target tissues, which result in maintenance of 
circulating glucose levels within normal ranges.  
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In healthy individuals, circulating levels of glucose are normally maintained 
within a physiological concentration range of approximately 60–100 iumilligrams per 
deciliter (mg/dL) in the fasted state. Food intake results in a rapid increase in the 
circulating levels of glucose to as much as ~200mg/dL within 1hr. This postprandial 
hyperglycemia induces the release of insulin into the circulation in order to bring 
circulating glucose concentrations in circulation back down to normal levels. Disruption 
of insulin’s ability to stimulate glucose uptake by its target tissues, especially in the case 
of skeletal muscle, results in a range of negative physiological outcomes resulting from 
bouts of both acute and chronic hyperglycemia. 
 If left unchecked, chronic hyperglycemia is a dangerous condition that contributes 
to the development of a variety of diseases such as metabolic syndrome, adult onset Type 
2 diabetes mellitus, gout, blindness and many cancers. The latest data from the National 
Health and Nutrition Examination Surveys found that 33% of adults living in the U.S. 
have metabolic syndrome, a condition exemplified by chronically high levels of 
circulating glucose concentrations and increased risk of adult-onset diabetes mellitus 
(Type 2 diabetes). The condition in which insulin stimulation of target tissues fails to 
elicit an adequate glucose uptake response is called insulin resistance/glucose intolerance, 
and further exacerbates the effects of chronic hyperglycemia due to decreased insulin-
stimulated uptake of glucose by insulin resistant target tissues, especially skeletal muscle. 
Insulin resistance can be induced by poor diet [1, 2] and chronic physical inactivity [3-
10], both of which unfortunately plague the typical American lifestyle.  
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Glucose Uptake in Skeletal Muscle 
Skeletal muscle is the largest insulin-sensitive tissue in the body and is the 
primary target for insulin-stimulated glucose uptake. As with all living cells in the body, 
glucose must pass through specific glucose transporters in the plasma membrane 
(specifically referred to as the sarcolemma in muscle cells) in order to enter the cell 
cytoplasm to be metabolized. As with many types of transmembrane signaling which rely 
on channel proteins that span the lipid bilayer of cell membranes, different cell types 
express different channel protein isoforms related to the function of the particular cell in 
which they are expressed. In the case of transmembrane glucose transporters, all cell 
types express a common isoform of the channel protein known as glucose transporter 1 
(GLUT1). GLUT1 is a highly evolutionary-conserved protein constitutively expressed in 
the plasma membrane of all cell types, including the sarcolemma (SL) of skeletal 
myofibers, and is responsible for the basal glucose uptake essential for energy production 
[11]. GLUT1 content in the sarcolemma is not affected by acute exercise or insulin 
stimulation, however GLUT1 biosynthesis is [12]. Therefore, long-term basal uptake can 
be affected by daily exercise and insulin-stimulation. 
Another major type of glucose transporter is the GLUT4 isoform, found 
predominantly in skeletal muscle cells, cardiac muscle cells, and adipocytes. Unlike 
GLUT1, which is primarily localized to the external plasma membrane of adipocytes and 
SL membranes of muscle cells, GLUT4 is primarily localized to internal membrane 
domains within these cell types and only translocates to the plasma/SL membrane 
following insulin stimulation of the target cell, and additionally in the case of skeletal 
muscle specifically, upon contraction and/or physical activity [13-15]. 
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As a transmembrane protein, GLUT4 is embedded within internal membranes and 
must be translocated to the external plasma/SL membrane through an exocytosis-like 
mechanism before it can transport glucose from the interstitial fluid across the plasma/SL 
membrane into the cell cytoplasm. While the exact sequence of events required for the 
translocation of GLUT4 from internal to external membranes is as yet not fully 
understood, experimental evidence suggests that it is under the control of several 
intracellular signaling pathways and ultimately, a membrane-membrane fusion event 
modulated by a series of docking proteins.  As is the case with adipocytes, insulin 
stimulation of skeletal muscle myofibers results in translocation of GLUT4 from internal 
membrane stores (i.e. the sarcoplasmic reticulum – SR - membrane) to the external 
plasma membrane (i.e. sarcolemma membrane – SL), thereby increasing the rate and 
amount of glucose taken up by the myofiber. Insulin-stimulated, GLUT4-mediated 
glucose uptake by skeletal muscle is responsible for removal of 70% to 80% of the 
increased amounts of circulating glucose observed during postprandial hyperglycemia 
after food intake. As such, skeletal muscle tissue and its overall sensitivity to circulating 
insulin levels is a critical factor in maintaining circulating blood glucose levels within 
safe, normal ranges [16, 17] and preventing the development of chronic hyperglycemia. 
In addition to direct insulin stimulation, GLUT4 translocation from the internal 
SR membrane to the external SL membrane also occurs in response to skeletal muscle 
contractile activity induced during physical activity/exercise. Skeletal muscle contractile 
activity, even in the absence of insulin stimulation, results in the translocation of large 
amounts of GLUT4 from internal SR membrane stores to the SL membrane of the 
myofiber. Contraction-induced GLUT4 translocation results in a rapid and substantial 
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increase in glucose uptake from the circulation by the myofiber [14], in order to satisfy 
the increased metabolic needs of the contracting skeletal muscle tissue. As such, 
increased GLUT4-mediated uptake of circulating glucose in response to voluntary muscle 
contraction during physical activity is also a critical factor in maintaining circulating 
glucose levels within safe, normal ranges and preventing the development of chronic 
hyperglycemia. While there are many documented health benefits of regular exercise and 
a physically active lifestyle, such as a reduction in the risk of Type 2 diabetes, obesity, 
cancer and chronic inflammation, it can be argued that many of the health benefits 
attributed to regular exercise may be directly related to the role of skeletal muscle 
GLUT4-mediated glucose uptake in that the maintenance of normal circulating glucose 
levels and the prevention of chronic hyperglycemia. 
The classic model of insulin-stimulated glucose uptake by GLUT4 in individual 
cells is primarily based on experimental studies carried out in isolated or cultured 
adipocytes. Many, if not all, of the same signaling molecules that make up the canonical 
insulin signaling pathway are common to both adipocytes and skeletal myofibers. Both 
cell types ultimately respond to insulin stimulation in the same manner, namely 
translocation of GLUT4 from internal membrane stores to the external membrane 
resulting in increased glucose uptake. In the case of skeletal muscle, insulin-mediated 
glucose uptake begins with ligand (i.e. insulin) binding of the insulin receptor located on 
the SL membrane. Insulin receptors (IR) are localized within cholesterol-rich micro-
domains or “lipid rafts” located within the SL membrane of the myofiber, specifically a 
subset of lipid rafts called caveolae [14, 18-23]. These cholesterol-rich membrane micro-
domains constitute a considerable portion of the total SL membrane fraction, are less 
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fluid and more ordered than the surrounding regions of the SL membrane, and harbor a 
unique set of receptors and membrane proteins involved in a range of other important 
signal transduction pathways in addition to insulin signaling [19, 22]. 
 
Cholesterol and Myofiber Membrane Content 
Cholesterol is a small, amphipathic molecule having both polar and non-polar 
regions that exhibits both hydrophilic and hydrophobic properties. Found in all 
mammalian membranes, cholesterol’s amphipathic properties allow it to pack between 
the phospholipids of the membrane bilayer were it serves an important structural support 
role increasing the overall tensile strength of the membrane. Because of its amphipathic 
nature, cholesterol is also capable of forming a molecular sheath around predominantly 
hydrophilic transmembrane proteins, such as the insulin receptor (IR) or GLUT channels, 
allowing the hydrophilic transmembrane proteins to span the hydrophobic regions of the 
lipid bilayer. Further, in cholesterol-enriched membrane microdomains such as caveolae, 
increased packing of cholesterol within the bilayer region locally increases membrane 
order and membrane rigidity, while decreasing membrane permeability [24]. 
Modulation of membrane cholesterol content has been shown to impact not only 
the mechanical properties of cell membranes but also the fidelity of a range of 
transmembrane signaling pathways in a variety of cell types including skeletal muscle 
[13, 18, 25]. Transmembrane signaling involved in calcium homeostatis, insulin signaling 
and other cell signaling-related endocytotic events all appear to be related to the 
cholesterol content of the membrane. These effects have been attributed to the ability or 
inability of these signaling proteins to undergo conformational changes during ligand 
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binding/activation related to the relative cholesterol content of the membrane region in 
which these signaling proteins normally reside. Interestingly, caveolae located in the 
plasma membrane are also the docking site for internal membrane GLUT4 trafficking 
vesicles [13, 18] suggesting that the cholesterol content of these membrane microdomains 
may also play a role in modulating GLUT4 translocation, in addition to the impact of 
membrane cholesterol content on the fidelity of transmembrane signaling by proteins 
residing within membrane caveolae. 
 
Cholesterol and Insulin Resistance 
Evidence to suggest that membrane cholesterol content is related to the overall 
glucose uptake process comes from the observation that depletion of plasma membrane 
cholesterol in adipocytes results in increased GLUT4 translocation and subsequent 
glucose uptake in this cell type [13, 18]. It is currently unknown if changes in the 
cholesterol content of skeletal muscle fiber membranes, either in the caveolae of the 
external SL where IR receptors reside, or the internal SR membrane components where 
GLUT4 channels reside, results in similar modulation of insulin signaling, GLUT4 
translocation events or overall glucose uptake by skeletal muscle tissue. However, whole 
animal studies utilizing methyl-β-cyclodextrin (MβC) administration to generally deplete 
cellular membrane cholesterol content resulted in increased GLUT4-dependent glucose 
uptake and reduced insulin resistance in obese mice [2] suggesting that membrane 
cholesterol content may be linked to insulin-dependent signaling pathways and glucose 
uptake in skeletal muscle.  
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In skeletal muscle, ligand binding of the IR normally results in the 
phosphorylation of the insulin receptor substrate (IRS), in turn activating the PI3K/Akt 
signaling pathway inducing GLUT4 translocation to the sarcolemma [13, 18]. In addition, 
GLUT4 vesicle fusion is also dependent on another insulin-stimulated signaling pathway 
distinct from the PI3K/Akt pathway. In a separate pool of insulin receptors, ligand 
binding initiates the assembly of the CrkII-C3G/Exo70 exocytosis complex, which 
appears to be responsible for the final fusion step of GLUT4 vesicle trafficking [18, 26-
30]. Experimental evidence suggests that chronic hyperglycemia leads to insulin 
resistance through a negative feedback loop involving up-regulation of specific signaling 
molecules in the PI3K/Akt pathway, namely mTORC1 and SK6, that in turn inhibit IRS 
phosphorylation [31]. Perversely, chronic over stimulation by insulin (i.e. chronic 
hyperinsulinemia) can also induce insulin resistance by over-stimulation of IR and by 
over activation of mTOR and SK6 as part of the PI3K/Akt signaling pathway [31].  
While several molecular mechanisms have been identified that may explain 
chronic hyperglycemia-induced and hyperinsulinemia-induced insulin resistance in 
skeletal muscle, increases in SL membrane cholesterol due to elevated circulating levels 
of cholesterol may also contribute. For example, Bonora et al. demonstrated the 
prevalence of insulin resistance in various metabolic disorders and found insulin 
resistance to be present in 53% of all hypercholesterolemia patients, 84% of 
hypertriglyceridemia patients, and 88% of subjects with low circulating levels of high-
density lipoprotein (HDL) [32]. Further, diet-induced hypercholesterolemia has been 
shown to increase membrane cholesterol in the skeletal muscle of obese mice [1, 2], 
specifically the T-tubule system of the SL membrane [2], and to cause a dysfunction in 
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GLUT4 vesicle transport due to a reduction in the formation of polymerized F-actin 
required for vesicle translocation [1]. It has also been demonstrated that lowering 
membrane cholesterol using methyl-β-cyclodextrin (MβC) increases GLUT4-dependent 
glucose uptake and reduces insulin resistance in obese mice [2].  
 
Models for Studying Membrane Cholesterol and Insulin-Stimulated Glucose Uptake 
The effect of altered plasma membrane cholesterol content on insulin stimulation 
has been studied extensively in vitro using 3T3-L1 adipocytes [13, 18]. For example, 
large-scale membrane cholesterol depletion using MβC or inhibitors of cholesterol 
biosynthesis such as chromium has been shown to inhibit IR autophophorylation, IRS-1 
phosphorylation, glucose uptake, and activation of the PI3K/Akt pathway in this cell type 
[33-36]. Counter-intuitively, partial depletion of membrane cholesterol using chromium 
exposure has been shown to increase GLUT4 translocation and glucose uptake in 3T3-L1 
adipocytes [37]. However, to date it is unclear that the effects of artificially modulating 
membrane cholesterol content previously described in cultured adipocytes accurately 
mimics in vivo cellular responses to hypercholesterolemia in general, or the effects of 
hypercholesterolemia on insulin signaling, GLUT4 translocation and/or glucose uptake in 
skeletal muscle tissue specifically.  
Considering skeletal muscle is one of the most important tissues in the body as it 
relates to insulin-stimulated glucose uptake and whole body glucose homeostasis, an in 
vitro model that more closely resembles a functional skeletal muscle fiber may be better 
suited than the current adipocyte models for investigating the underlying molecular 
mechanisms involved in insulin-stimulated glucose uptake in skeletal muscle tissue. 
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There is no doubt that normal insulin signaling and glucose uptake in skeletal myofibers 
in vivo involve the interaction of a complex set of transmembrane and intracellular 
signaling pathways that rely on specific signaling proteins located in discrete but spatially 
related membrane systems. Whole animal and ex vivo tissue studies have provided 
significant understanding of these cellular events but still have many confounding 
variables which are difficult if not impossible to control when studying individual 
elements of this response. While the use of cultured myocyte cell lines to further study 
and dissect the underlying cellular mechanisms involved in normal myofiber insulin 
signaling and glucose uptake in vivo, as well as investigating the etiology of a number of 
pathological conditions such as insulin resistance and glucose tolerance would appear to 
be a logical approach, the use of such tissue culture models also present several 
significant experimental challenges. 
 
Experimental Challenges 
Cultured myocytes are individual cells that lack the highly organized contractile 
elements and membrane systems found in fully formed, multi-cellular myofibers. As 
such, cultured myocytes do not provide an ideal model for studying the complex cascade 
of events already known to be involved in insulin signaling and glucose uptake by 
myofibers in vivo. In addition, myocyres do not provide an appropriate experimental 
platform to study the pathological effects of environmental conditions such as chronic 
hyperglycemia or chronic hypercholesterolemia, or the underlying etiology of diseases 
states related to these conditions in vivo, such as insulin resistance or Type 2 diabetes. To 
overcome some of these experimental challenges and address the need for a model more 
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closely resembling myofibers in vivo, individual myocyte cells can be induced to fuse 
together in culture to form multi-cellular myotube structures analogous to myofibers in 
vivo. However, depending on the type of myocytes utilized and the culture conditions 
under which they are grown, it is still unclear if such myotube models truly exhibit the 
differentiated characteristics needed to fully mimic the cellular mechanisms involved in 
insulin signaling and glucose uptake in skeletal muscle tissue in vivo. 
Both mouse C2C12 and rat L6 skeletal muscle-derived cell lines have been 
previously used to study insulin signaling and glucose uptake mechanisms in vitro[12, 
38-45]. While the L6 cell line has been used to investigate insulin-stimulated GLUT4 
translocation and glucose uptake [46], L6 myotubes do not form sarcomeres efficiently 
and lack the potential for contractile activity [47, 48]. This suggests that the membrane 
systems involved not only in the control of excitation-contraction (EC) coupling, but also 
insulin signaling, GLUT4 translocation and ultimately insulin-stimulated glucose uptake 
are missing or have not fully formed in these myotubes. In contrast, the C2C12 myocyte 
cell line can be used to generate myotubes that form sarcomeres and develop contractile 
potential [47, 49] in culture. However, the use of the C2C12 mouse myoblast cell line has 
provided contradictory information regarding insulin-stimulated GLUT4 translocation 
and glucose uptake.  A number of researchers have reported little or no glucose uptake in 
response to insulin stimulation in either C2C12 myocytes or myotubes [12, 38, 44, 50], 
while others have observed limited insulin-stimulated glucose uptake [43] and GLUT4 
translocation [39] but only in C2C12 myotubes. Further, those who have reported an 
insulin-stimulated glucose uptake response in C2C12 myotubes describe a blunted insulin 
response that varies from culture passage to culture passage [43]. 
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The contradictory information reported with regard to insulin signaling and 
subsequent glucose uptake in cultured myocytes and myotubes may be related to 
confounding experimental conditions that to date have not been recognized as such. 
Interestingly, much of the literature investigating insulin stimulated glucose uptake by 
cultured myocytes or myotubes does not report the precise glucose concentrations under 
which these cells were propagated or tested [38, 50]. This critical factor may explain the 
contradictory results previously reported with regard to whether or not cultured myocytes 
and myotubes respond similarly to myofibers in vivo in response to insulin stimulation. 
For example, several researchers have demonstrated that even short-term incubation in 
tissue culture medium containing the high levels of glucose normally utilized in standard 
media preparations (25mM, or physiologically speaking 450mg/dL) appears to cause 
insulin resistance in a number of cultured cell types including skeletal muscle, while in 
some studies insulin-stimulated glucose uptake was observed only after pre-incubation in 
low-glucose media (5.5mM or 100mg/dL glucose) [31, 43]. 
Additionally, Nedachi et al. also demonstrated that the effects of altering glucose 
concentration in the tissue culture medium was extremely rapid as exposure to high 
glucose concentrations of 25mM (450mgd/L) after culture in low glucose concentrations 
(5.5mM, 100mg/dL) impaired subsequent insulin-stimulated 2-deoxyglucose (2DG) 
uptake within 5 minutes [43]. Further evidence to suggest the importance of controlling 
culture conditions as it relates to glucose concentration comes from Leonitieva et al. who 
demonstrated impaired insulin-stimulated Akt phosphorylation in C2C12 myoblasts and 
inhibition of glucose uptake in retinal pigment epithelial (RPE) cells when cultured in a 
standard high glucose (25mM or 450 mg/dL) medium preparations, while exposure to the 
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same medium preparation containing low glucose (5.5mM, 100mg/dL) restored insulin 
sensitivity in both these cells types [31]. Taken together, these experimental data suggest 
that to develop a tissue culture model of insulin-stimulated glucose uptake in skeletal 
muscle will require not only the use of the appropriate cell type capable exhibiting the 
structural and molecular organization of skeletal myofibers in vivo, but will also require 
significant control of culture conditions such as glucose medium concentration. Without 
taking such culture conditions into account, it will be impossible to ensure that any 
effects related to insulin-stimulated glucose uptake observed in vitro accurately reflect 
cellular responses to pathological conditions such as chronic hyperglycemia or 
hypercholesetrolremia related to the development of insulin resistance and glucose 
intolerance of skeletal muscle in vivo.  
 
Summary 
Hypercholesterolemia and/or physical inactivity has been shown to contribute to 
insulin resistance and glucose intolerance in the whole animal. Altered cholesterol 
content in the plasma membrane of adipocytes has been shown to affect various signaling 
pathways involved in GLUT4 translocation and glucose uptake in vitro, while animal and 
human models suggest a strong association between hypercholesterolemia, increased 
membrane cholesterol, and insulin resistance. An increasing amount of experimental 
evidence suggests that these pathological effects may be specifically correlated with an 
increase in membrane cholesterol content in skeletal muscle fibers. To date, the 
pathological impact of increased membrane cholesterol content on insulin-stimulated 
glucose uptake in skeletal muscle myofibers has yet to be directly investigated, either in 
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vivo or in vitro. Furthermore, many of the experimental findings regarding the underlying 
cellular mechanisms involved in insulin-stimulated glucose uptake in cultured muscle 
cells are confounded by a lack of adequate control of culture conditions, such as glucose 
media concentrations, making it difficult to discern whether or not these models reflect 
the normal insulin-stimulated glucose uptake response in skeletal myofibers in vivo, or 
rather, the effects of chronic hyperglycemic culture conditions on this response. 
Therefore the overall aim of this study is to develop a reliable tissue culture model 
utilizing differentiated C2C12 myotubes to study insulin-stimulated glucose uptake under 
physiologically normal glycemic conditions. In turn, this model will then be used to 
investigate the putative pathological effects of altered membrane cholesterol content on 
insulin-stimulated glucose uptake and its potential role in the etiology of skeletal muscle 
insulin resistance as it relates to the development of metabolic syndrome and the onset of 
Type 2 diabetes in vivo. 
 
Problem Statement 
 Hypercholesterolemia has been identified as a major confounding factor for 
insulin resistance and type 2 diabetes which may be related to an increase in membrane 
cholesterol in muscle fibers leading to a decrease in insulin sensitivity and subsequent 
glucose uptake. While the role of increased membrane cholesterol content in impaired 
insulin signaling and glucose uptake in skeletal muscle is not well understood, previous 
experimental evidence is consistent with the concept that such a cholesterol-mediated 
effect is related to disruption of GLUT4 membrane translocation that relies on 
membrane-membrane fusion events rather than direct disruption of insulin receptor 
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activation. Currently, there is no suitable model for studying the complex cascade of 
events known to be involved in insulin signaling and glucose uptake by myofibers in 
vivo, nor any defined in vitro experimental platform to study the pathological effects of 
increased membrane cholesterol content on insulin-stimulated glucose uptake in skeletal 
muscle or the role of increased membrane content on the underlying etiology of diseases 
states such as insulin resistance or Type 2 diabetes.  
Therefore, the overall aim of this study is to develop a reliable and reproducible 
tissue culture model utilizing differentiated C2C12 to study insulin-stimulated glucose 
uptake under physiologically normal glycemic conditions. In turn, this model will then be 
used to investigate the putative pathological effects of altered membrane cholesterol 
content on insulin-stimulated glucose uptake and its potential role in the etiology of 
insulin resistance in skeletal muscle as it relates to the development of metabolic 
syndrome and the onset of Type 2 diabetes. Furthermore, this model will be used to 
selectively enrich specific membrane systems within these cultured myotubes (i.e. either 
the sarcolemma/T-tubule or sarcoplasmic reticulum membrane systems) in order to 
further investigate whether differential membrane cholesterol content may be directly 
related to the impairment of GLUT4 translocation observed in insulin resistant skeletal 
muscle of hypercholesterolemic individuals. 
 
Research Objectives 
1. Develop a reproducible tissue culture model of insulin-stimulated glucose uptake in skeletal 
muscle differentiated myotubes derived from the C2C12 myocyte cell line utilizing a non-
metabolizable, fluorescent analog of glucose (2-BNDG) to quantify glucose uptake response 
in this cell type. 
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2. Using a combination of a cholesterol/methyl-β-cyclodextrin (MβC) complex and a 
fluorescent analog of cholesterol to confirm spatial localization, define a set of pulse/chase 
tissue culture conditions capable of selectively modulating the cholesterol content of both the 
external SL and internal SR membranes in cultured differentiated myotubes. 
3. Characterize the effects of selectively modulating the cholesterol content of either SL or SR 
membranes on insulin-stimulated glucose uptake in cultured differentiated myotubes. 
 
Research Hypothesis 
Experiment 1: 
Hypothesis 1: C2C12 myocytes can be induced to form multi-cellular myotube 
structures in culture which exhibit sub-cellular organization and express 
differentiation markers similar to those observed in skeletal myofibers in vivo. 
 
Hypothesis 2: Differentiated C2C12 myotubes will exhibit a dose-dependent, 
insulin-stimulated glucose uptake response when grown under appropriate 
normoglycemic (80mg/dL) tissue culture conditions. 
 
Experiment 2:  
Hypothesis 3: Increasing the membrane cholesterol content of differentiated 
C2C12 myotubes by exposing them to a cholesterol/MβC complex in culture will 
result in the inhibition of insulin-stimulated glucose uptake compared to control 
conditions. 
Hypothesis 4: Selective cholesterol enrichment of either the external SL 
membranes or the internal SR membranes of differentiated C2C12 myotubes can 
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be achieved using a cholesterol/MβC complex combined with a set of defined 
pulse/chase culture conditions. 
 
Experiment 3:  
Hypothesis 5: Selective cholesterol enrichment of the external SL membrane of 
differentiated C2C12 will be achived using a short-term exposure to 
cholesterol/MβC complex resulting in the inhibition of insulin-stimulated glucose 
uptake compared to control conditions. 
 
Hypothesis 6: Selective cholesterol enrichment of the internal SR membrane of 
differentiated C2C12 myotubes will be achieved using a defined pulse/chase 
exposure to cholesterol/MβC complex resulting in the inhibition of insulin-
stimulated glucose uptake compared to control conditions. 
 
Hypothesis 7: Similar levels of cholesterol enrichment of both the SL and SR 
membranes of differentiated C2C12 myotubes using a combination of both acute 
and pulse/chase exposure to cholesterol/MβC complex will not inhibit insulin-
stimulated glucose uptake compared to control conditions. 
 
Outline 
An overview of this proposal is presented which summarizes the details used in 
establishing cholesterol’s effects on insulin-stimulated glucose uptake in cultured 
myotubes. 
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Chapter 1 (introduction) introduces the subject and summarizes the basis and 
importance for developing the proposed model and conducting the proposed experiments. 
Chapter 2 (Literature Review) presents background information behind the main 
topics covered. First, we provide an overview of the importance of normal insulin-
stimulated glucose uptake and the consequences of an impaired insulin response. Next, 
the biochemical signaling pathways involved in normal insulin signaling and the function 
of cholesterol within membranes. Then, a discussion on how altered cholesterol affects 
insulin signaling. Finally, an overview of possible cell culture models that can be used to 
study the effect of altered membrane cholesterol content on insulin-stimulated glucose 
uptake and the experimental challenges that must be accounted for in developing such a 
model.  
 
Contributions to the Field 
Insulin resistance and Diabetes Mellitus 2 are chronic diseases that plaque 
American society. Also, hypercholesterolemia has been strongly correlated both with 
insulin resistance and diabetes mellitus 2, as well as increased sarcolemma/T-tubule 
cholesterol content and impaired GLUT4 translocation. The existing literature provides 
support for the concept that diet-induced hypercholesterolemia may ultimately lead to 
insulin resistance in skeletal muscle by altering the cholesterol content of skeletal muscle 
membranes leading to the disruption of a key membrane-mediated event, namely GLUT4 
translocation. This study aims to demonstrate that insulin-stimulated glucose uptake is 
inhibited by increased cholesterol membrane content, and that the inhibition is 
specifically related to differential cholesterol enrichment of internal sarcoplasmic 
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reticulum membranes rather than just the external sarcolemma/T-tubule membrane. 
These will add to the literature by providing a highly reproducible tissue culture model of 
skeletal muscle myofibers in which to investigate a range of physiologically and 
pathologically skeletal muscle responses, demonstrate a direct link between muscle 
membrane cholesterol content and insulin resistance, and provide valuable information in 
understanding the cellular mechanisms involved in the etiology and onset of insulin 
resistance and diabetes mellitus 2. 
 
Definition of Important Terms and Abbreviations: 
SL: Sarcolemma/T-tubule membrane 
SR: Sarcoplasmic Reticulum membrane 
IR: Insulin receptor 
HDL: High Density Lipoprotein 
LDL: Low density lipoprotein 
GLUT1: Glucose Transporter 1 
GLUT4: Glucose Transporter 4 
MβC: Methyl Beta Cyclodextrin 
WSC: Water Soluble Cholesterol (i.e.  Cholesterol/ Methyl Beta Cyclodextrin Complex) 
2-NBDG: 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose 
MHC: Myosin Heavy Chain 
DHP: Dihydropyridine 
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Chapter 2 – Review of Literature 
Skeletal Muscle and Glucose Homeostasis 
 Skeletal muscle is responsible not only for the generation of force required for 
musculoskeletal movement but is also one of the most metabolically active tissues in the 
body. Representing up to 40% of total body mass in humans, skeletal muscle is a primary 
consumer of circulating glucose and important regulator of whole body glucose 
homeostasis. Over and above the levels required to maintain basal cellular function, 
glucose uptake into skeletal muscle is stimulated by exercise in order to meet the energy 
needs of contractile activity, or by insulin and its signaling pathway in response to 
increased blood-glucose concentrations. Impairments in the insulin signaling pathway 
resulting in insulin resistance or glucose tolerance are caused by and/or associated with 
obesity, chronic inactivity, diet, and hypercholesterolemia, and can lead to serious 
adverse health conditions including diabetes mellitus 2 (Type 2 diabetes), gout, blindness, 
and increased risk of cancer. [10, 32, 51-59]. 
 Under normal conditions, high concentrations of glucose in circulation induce 
production of insulin by pancreatic beta cells in order to stimulate glucose deposition out 
of the blood [60, 61]. The primary targets of insulin stimulation and glucose deposition 
include adipocytes, cardiac muscle, and the largest insulin-sensitive organ in the body: 
skeletal muscle. Very low concentrations of glucose in circulation stimulation production 
of glucagon by pancreatic alpha cells in order to stimulation gluconeogenesis, or the 
production of carbohydrates from lipids or proteins, by the liver. The actions of both 
insulin and glucagon aim to keep concentrations of glucose in the blood at safe levels, 
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typically between 3.9mM and 5.6mM [62]. Very low concentrations of glucose can lead 
an individual to lose consciousness, while chronic high concentration of glucose in 
circulation contributes to a process called glycosylation, where a carbohydrate forms a 
covalent bond with a protein. Many proteins require this process, but when 
concentrations of glucose are too high glycosylation can occur for proteins not meant to 
be glycosylated, which diminishes the function of the protein. For example, glucose 
reacts with the the NH2 terminal of the hemoglobin beta chain to form hemoglobin Acl, 
which is associated with, and used a common measurement to test for diabetes and 
control of glucose homeostasis [63]. 
 In healthy individuals, circulating levels of glucose are normally maintained 
within a physiological concentration range of approximately 60–100mg/deciliter in the 
fasted state. Food intake results in a rapid increase in the circulating levels of glucose to 
as much as ~200mg/dL within 1hr. This postprandial hyperglycemia induces the release 
of insulin into the circulation in order to bring glucose concentrations in circulation down 
to a safe level. As might be expected, disruption of insulin’s ability to stimulate glucose 
uptake by its target tissues, especially skeletal muscle, can and does result in significant 
negative outcomes associated with the onset of either acute or chronic hyperglycemia. 
  
Glucose Uptake in Skeletal Muscle  
Glucose Transporters 
Skeletal muscle is the largest insulin-sensitive tissue in the body and is the 
primary target for insulin-stimulated glucose uptake. Glucose must pass through specific 
Glucose Transporters (GLUT) in the membrane in order to enter the cell to be 
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metabolized. There are 12 known GLUT molecules (GLUT1 through GLUT12) that 
facilitate active transport of carbohydrates through the cell membrane into the cytoplasm. 
Some have affinities for carbohydrates such as fructose or sucrose, while others are 
specific to glucose [15]. There are two major GLUT molecules in skeletal myofibers, 
namely Glucose Transporter 1 (GLUT1), and Glucose Transporter 4 (GLUT4) [64]. 
GLUT1 is responsible for glucose uptake required to satisfy basal metabolic activity and 
is constitutively expressed in the plasma membrane of all cell types and the specifically 
the sarcolemma of skeletal muscle myofibers [11].  
 GLUT1 expression is upregulated by chronic activity of light to moderate 
intensity [65], as well as stimulation of the PI3K/Akt pathway as demonstrated using 
PI3K inhibitor wortmannin [66], the importance of which is discussed in detail later in 
this chapter. Exercise affects GLUT1 expression through exercise-induced activation of 
AMPK [67, 68]. 
The total amount of GLUT1 proteins present in the membrane of skeletal muscle 
does not change significantly in response to a single bout of exercise, nor acute 
stimulation by insulin [69]. In the case of chronic physical activity myofibers undergo 
significant protein turnover and remodeling, and as a result GLUT1 expression and 
localization in the myofiber sarcolemma membrane increases to meet the average basal 
metabolic need for glucose associated with myofiber hypertrophy. Skeletal muscle 
however, must be able to response to acute metabolic stimuli such as moderate to intense 
exercise, or, insulin stimulation when glucose concentrations in the circulation are high, 
by increasing the amount of glucose taken up by the myofiber. In response to acute 
stimulation of either type, skeletal muscle myofibers rely on a second related type of 
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transmembrane glucose transporter, GLUT4, which is stored in internl membrane 
vesicles called GLUT4 Storage Vesicles (GSVs) and rapidly translocated to the myofiber 
sarcolemma membrane in 
response to such stimuli. 
GLUT4 is expressed 
predominately in skeletal 
muscle, cardiac muscle, and 
adipocytes, and localized to 
internal membrane stores until 
stimulated to translocate [15]. 
In response to contractile 
activity (exercise) or insulin 
stimulation, large stores of GLUT4 transport vesicles translocate from internal 
membranes to the sarcolemma for a fast and substantial increase in glucose uptake by the 
myofiber [15]. Insulin-stimulated glucose uptake mediated via GLUT4 translocation is 
responsible for 70-80% of postprandial glucose deposition out of the circulation into 
skeletal muscle, making it critical for maintaining normal blood-glucose concentrations 
in circulation [70, 71]. Insulin plays a critical role in GLUT4 translocation by not one but 
two distinct signaling pathways, leading to both translocation and membrane fusion of 
GLUT4 transport vesicles with the sarcolemma. 
 GLUT4 is responsive to both insulin stimulation and exercise, through multiple 
biochemical signaling pathways, leading to translocation and tethering of GLUT4 
Storage Vesicles (GSVs) to the myofiber membrane.  Translocation involves the process 
Figure	1:	GLUT4	Translocation	
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of bringing GSVs containing GLUT4 from their budding site on the Trans-Golgi 
Network to the sarcolemma of the myofiber membrane, while tethering is the process of 
anchoring the GSVs to the membrane for fusion and ultimate integration of GLUT4 into 
the sarcolemma. Exercise induces translocation of GLUT4 Storage Vesicles (GSVs) 
through a Ca2+/CaMK dependent pathway, while insulin stimulates both translocation 
and tethering of GSVs through the PI3K/Akt and CAP/TC10 signaling pathways, 
respectively.  
 
Insulin-Stimulated 
GLUT4 Translocation 
The insulin 
receptor is comprised of 
4 individual proteins: 
two alpha subunits 
present on the cell 
surface, and two beta 
subunits that extend 
through the membrane. 
The alpha subunits bind with insulin from circulation resulting in a conformational 
change and autophosphorylation of the beta subunits, where one subunit phosphorylates 
the other. These phosphate ions are then cleaved and bound to Insulin Receptor Substrate 
1 (IRS1) [13, 18, 72]. Once IRS1 is phosphorylated it activates the critical 
Phosphoinnositol-3 Kinase (PI3K) / Protein Kinase B (Akt) pathway, which is involved 
Figure	2:	GLUT4-Dependent	Glucose	Uptake	
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in a number of cellular phenotypes including myofiber size [73], and glucose uptake [18, 
74]. The role of PI3K in GLUT4 translocation has been confirmed through chemical 
inhibition by wortmannin and LY294002, expression of dominant negative mutants, and 
PI3K antibodies which all inhibit GLUT4 translocation and glucose uptake [18, 74]. 
Akt has a complex role in insulin signaling, contributing through at least two 
isoforms of the Akt protein: Akt1 and Akt2 [18]. In response to IRS1 activation, the p85 
regulatory subunit of Phospho-inositol 3 Kinase (PI3K) catalyzes the phosphorylation of 
PIP2 to form PIP3 [74]..The phosphate ion on PIP3 is then passed to and activates both 
protein kinase B (Akt) and 3’ phosphoinositol-dependent kinase-1 (PDK-1), which in 
turn activates both Akt and atypical protein kinase C (PKC). Akt2 regulates GLUT4 
translocation through phosphorylation-inhibition of a negative regulator of exocytosis 
vesicle trafficking. Akt2 is phosphorylated at two binding sites; its Thr308 and Ser473 
domains, both activated by insulin. Akt’s Thr308 residue is phosphorylated by PDK-1, 
while Ser473 is phosphorylated by mTORC2. Ser473 and mTORC2 are part of a 
feedback loop where mTORC2 is activated by mTORC1, which in turn is activated by 
phosphorylation of Akt’s Thr308 residue. It has been demonstrated that it is specifically 
phosphorylation at the Thr308 residue that leads to GLUT4 translocation [75]. Akt 
activation in response to insulin stimulation results in the phosphorylation of Akt 
Substrate 160kd (AS160) at five distinct phosphorylation sites, inhibiting its activity in 
GSV retention [76-80]. AS160 regulates GLUT4 trafficking through its GTPase 
Activating Protein (GAP) domains that bind to Rab proteins 6,8,10 and 14. Rab proteins 
function by holding the GLUT4 storage vesicles (GSVs) along actin filaments as the 
GSVs are trafficked towards the sarcolemma membrane. In short, insulin stimulated Akt 
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activation inhibits AS160, allowing Rab proteins to facilitate GLUT4 translocation [14, 
76, 81-83].  
 
Insulin-Stimulated GSV Docking 
From a separate pool of insulin receptors originates a separate pathway 
independent of PI3K/Akt and also residing in caveolae. In response to insulin receptor 
autophosphorylation, a caveolae membrane-bound adaptor protein with Pleckstrin and 
Src homology domains (APS) catalyses the phosphorylation of Cbl Associated Protein 
(CAP). CAP then recruits, phosphorylates, and binds Cbl to the caveolae membrane. 
Activated Cbl provides docking sites for and recruits the CrkII/C3G complex. This 
complex binding to Cbl is what determines the GSVs site of fusion into the membrane. 
Once bound, the C3G subunit reveals active phosphorylation sites for TC10, a small 
GTPase protein. TC10 activation initiates the assembly of GLUT4 exocytosis complex 
(Exo) consisting of Exo70, Sec6 and Sec8 subunits, and is dependent on being localized 
to caveolae [18, 26-30, 57]. This step is responsible for catalyzing the final tethering step 
in GLUT4 translocation and fusion to the myofiber membrane. This process is essentially 
an exocytosis mechanism in same way a cell excretes waste products, where the vesicle 
becomes part of the out membrane and the vesicle contents are expelled. However GSVs 
have GLUT4 imbedded in membrane of the vesicle, adding GLUT4 to the myofiber 
sarcolemma membrane as GSV membranes fuse with the outer membrane.  
 
 
Exercise Induced GLUT4 Translocation and Fusion 
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Exercise-induced GLUT4 translocation is a multifactorial process and includes 
signaling pathway intermediates such as calcium dependent calmodulin protein kinases 
(CaMKK and CaMKII), AS160, AMPK, and Kv1.3. [84-87]. AMPK is responsive to 
changes in the intracellular ATP:ADP ratio which shifts during exercise. In response to a 
decrease in the AP:ADP ratio associated with contractile activity,. AMPK is converted to 
an active form which in turn inhibits activation of Akt which is responsible for carrying 
out GLUT4 translocation via insulin [84]. The AMP analog AICAR has been used to 
demonstrate that activation of AMPK significantly increases glucose uptake [88], 
however AMPK inhibition or attenuation has little effect [84]. 
While exercise induced activation of AMPK has been shown to be the key factor 
in the initiation of exercise-induce GLUT4 translocation, calcium also appears to be 
critical for this process to occur. Calcium (Ca2+) is also a major contributor to exercise 
induced GLUT4 translocation through its intermittent fluctuations in cytoplasmic 
concentrations during physical activity. A contraction-stimulating action potential is 
delivered to the sarcomeres of a myofiber through the Traverse Tubule (T-Tubule) 
membrane system which is an intracellular extension of the external sarcolemma 
membrane. The T-Tubule system carries post-synaptic action potentials to the 
Dihydropyridine (DHP) receptor, an ion-gated channel located in the T-Tubule 
membrane juxtaposed to the Ryanadine (RyR) channels located in the terminal cisternae 
of the internal SR membrane which together form the Triad region of the myofiber T-
Tubule/SR membrane system. The RyR channel is a voltage sensing Calcium channel 
that when stimulated by the DHP receptor in response to an action potention, releases 
Ca2+ into the sarcoplasm of the myofiber causing a muscle contraction. Ca2+ release from 
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the SR causes a muscle contraction by uncovering the myosin heavy chain binding sites 
on troponin along the actin filament, a process collectively known as excitation-
cotraction (EC) coupling. Sustained physical activity can increase [Ca2+] by 100-fold 
[89], which contributes to GSV fusion and GLUT4 translocation to the sarcolemma. 
The precise mechanism of calcium-induced GSV translocation is currently 
unclear, but there are several molecules known to be involved that are activated by 
exercise-induced release of calcium within the sarcoplasm of the myofiber. Several 
studies have shown Ca+ /calmodulin dependent kinases (CaMK) to be critical for the 
process. Wright et al. used the calmodulin inhibitor KN-93 to block activation of CaMKs 
and GSV translocation, demonstrating the necessity for Ca+/calmodulin dependent 
activation of CaMKs.  Witczak also demonstrated the role of CaMKK by using viral 
vectors transfected into mouse muscle inducing an overexpression of CaMKK and a 2.5 
fold increase in insulin-stimulated glucose uptake. Angin et al. demonstrated this same 
effect in cardiomyocytes [87].  
Both Wright and Witczak et al also demonstrated this effect is independent of 
AMPK by using CaMKK inhibitor STO-609 coupled with electrical stimulation-induced 
contraction [90, 91], while Nui et al. demonstrated that contraction induced AMPK 
activation induced GLUT4 translocation independent of CaMKII [92]. Not all data 
demonstrates CaMKK and AMPK to be separate pathways however; Jensen et al. used 
the same CaMKK inhibitor STO-609 and found a decrease in muscle glucose uptake 
through an AMPK-dependent pathway [93].   
Both AMPK and calmodulin are thought to interact with Akt Substrate of 160kd 
(AS160). Kramer et al. demonstrated that both AMPK activation and contraction 
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stimulated glucose uptake [79], and also found that mutations in AMPKs binding sites 
render AS160 unresponsive to AMPK [79]. AS160 also has calmodulin binding domains, 
mutations of which inhibit contraction induced glucose uptake [79]. 
Aside from CaMKK, AMPK and AS160, a voltage-gated potassium channel 
(Kv1.3) and SNARE-dependent exocytosis have also been identified as calcium-
dependent mediator of GLUT4 translocation to the sarcolemma [85]. Li et al found that 
blocking the release of calcium from the SR in adipocytes allowed Kv1.3 to in turn block 
GLUT4 translocation. This demonstrates Kv1.3 as a negative regulator of GLUT4 
translocation that is inhibited by calcium release from the SR.  
Soluble N-ethylamaleimaide-sensitive factor attachment protein receptors 
(SNAREs) play a critical role in exocytosis [94], including GSV docking and fusion with 
the sarcolemma. GSV fusion is facilitated by soluble C2-domain factor Doc2b; Yu et al. 
demonstrated in a reconstituted proteoliposome fusion system that calcium is required for 
Doc2b to facilitate the fusion of GSVs to SNARE protein complex SNAP23 through two 
active calcium binding sites on its C2A and C2B domains [95]. Further, Yu et al. 
demonstrated that Doc2b significantly bends the membrane inward during SNARE 
dependent exocytosis. These studies demonstrate exercise-dependent calcium release to 
be a powerful mediator of GLUT4 translocation.  
 
 
 
Disregulation of Glucose Homeostasis and Insulin Resistance 
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In normal conditions increased blood-glucose concentrations initiate the 
production of insulin by the pancreas. The increased production of insulin stimulates 
glucose uptake in skeletal muscle bringing blood-glucose concentrations back to normal 
and safe levels. Impairments in insulin signaling, referred to as insulin resistance, render 
an individual unable to respond to increased glucose or insulin in circulation, which can 
result in chronic and dangerously high concentrations of glucose in the circulation and 
potential pathological levels of protein glycosylation. Insulin resistance can be induced 
by diet [1, 2], prolonged spaceflight 
[7] and chronic physical inactivity [3-
6, 10], and is the root cause of diabetes 
mellitus II, while significantly 
ncreasing the risk of developing gout, 
blindness and many types of cancer.  
Insulin signaling can be 
directly impaired through several 
molecular mechanisms. Chronic high 
concentrations of circulating glucose, or hyperglycemia, can cause insulin resistance 
through a negative feedback loop involving downstream targets of PI3K/Akt: mTORC1 
and SK6. High glucose concentrations over-stimulate mTORC1, in turn over-stimulating 
SK6, which directly inhibits phosphorylation of IRS1 by insulin receptors [31]. Chronic 
high concentrations of insulin, or hyperinsulinemia, cause insulin resistance through the 
same negative feedback loop that inhibits IRS1 activation, but through over-stimulation 
of IRS and the PI3K/Akt pathway leading to overstimulation of mTORC1[31]. 
Figure	3:	Insulin	Resistance	
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Hypercholesterolemia, and increased membrane cholesterol content has also been 
implicated in insulin resistance through its association with the disease in human models 
[32], as well as animal models [1]. 
 
Cholesterol and Myofiber Membrane Composition 
Our basic understanding of biological membranes is based on the concept of a 
lipid bilayer made up primarily of phospholipids in which a variey of other lipids and 
proteins are embedded. This prototypical model is collectively called the fluid mosaic 
model of membrane structure [96]. Though our understanding of membrane structure has 
evolved considerably since the fluid mosaic model was originally conceived, one critical 
aspect of the model remains, namely that biological membranes possess both fluid and 
gel properties resulting in regions of the membrane exhibiting local rigidity while 
remaining essentially fluid in its overall structure. Mammalian cellular membranes 
consist of a phospholipid bilayer composed mostly of glycophospholipids with 
hydrophilic glycogen heads and hydrophobic unsaturated fatty acid chain tails. The 
amphipathic nature of these phospholipids creates a stable membrane structure where the 
hydrophyllic heads form the extracellular and intracellular sides of the membrane, while 
the hydrophobic tails form the inner region of the membrane bilayer. This also means that 
transmembrane signaling and transport through this bilayer must occur through highly 
regulated mechanisms, and specialized transmembrane proteins with both hydrophilic 
and hydrophobic regions that allow them to reside within and pass through these 
hydrophobic and hydrophilic regions, respectively. One critical component of 
mammalian cell membranes is cholesterol, where the density of cholesterol within the 
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membrane can alter both membrane fluidity and rigidity [25, 97] while providing 
structural support to the phospholipids bilayer. Because of its amphipathic nature, 
cholesterol is also capable of forming a molecular sheath around predominantly 
hydrophilic transmembrane proteins, such as the insulin receptor (IR) or GLUT channels, 
allowing the hydrophilic transmembrane proteins to span the hydrophobic regions of the 
lipid bilayer. Further, in cholesterol-enriched membrane microdomains such as caveolae, 
increased packing of cholesterol within the bilayer region locally increases membrane 
order and membrane rigidity, while decreasing membrane permeability [24]. 
Transmembrane signaling and membrane fusion, such as that required for GLUT4 
translocation in skeletal myofibers is also dependent on cholesterol-rich microdomains. 
For example, caveolae located in the sarcolemma membrane are also the docking site for 
internal membrane GLUT4 trafficking vesicles [13, 18] suggesting that the cholesterol 
content of these membrane microdomains may also play a role in modulating GLUT4 
translocation 
 
Cholesterol Biosynthesis 
 Cholesterol is incorporated into membrane by exogenous sources, either 
synthesized with in the cell or taken from circulation. Synthesis with in the cell occurs in 
the endoplasmic reticulum of the cell and is initiated by Sterol Regulatory Element 
Binding Protein (SREBP) when membrane cholesterol content is low. SREBP is a 
transcription factor inducing the transcription of the genes responsible for the synthesis of 
cholesterol [98]. SREBP is also activated in response to exercise induced activation of 
AMPK [99]. Among the 40+ membrane bound proteins expressed and involved in the 
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process, the enzymatic activity of 3-hydroxy-3methylglutaryl-CoA reductase (HMG 
CoAR) is most critical as it is a rate limiting step in the production of the cholesterol 
precursor mevalonate [100].  Although myofibers do synthesize cholesterol, they 
predominately rely on endogenous LDL as their rate of synthesis is of the slowest in the 
body [101-103]. 
 
LDL Uptake and HDL Excretion 
Endogenous cholesterol production is inhibited when adequate amounts are 
obtained from diet sources. Cholesterol, triglycerides and phospholipids are hydrophobic 
and require carrier molecules to enter the circulation. After ingestion, cholesterol is 
packaged with other lipids into structures called “micelles” allowing cholesterol to pass 
through the walls of the small intestine. Once in the circulation, cholesterol and other 
lipids are re-packaged with a protein exterior, which forms a low-density lipoprotein 
(LDL). LDL receptors are located in specialized compartments within the sarcolemma 
called clathrin-coated pits, where LDL is consumed by the cell through a process called 
receptor mediated endocytosis. After binding, both LDL and the LDL receptor cross the 
cell membrane, while afterwards the receptor is detached and reincorporated back into 
the sarcolemma [104]. Excess cholesterol is either esterified within the sarcoplasmic 
reticulum by sterol o-acyltransferase for storage, or expelled out of the cell by ATP-
binding cassette transporters (ABCs) ABCA1 and ABCG1, which aid in both 
translocation to the membrane and packaging of free cholesterol into lipoproteins. 
Cholesterol leaves the cell packaged as a water-soluble, high-density lipoprotein (HDL) 
[105].  
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Cholesterol Trafficking to Internal Membranes 
Once inside the cell the LDL molecule is hydrolyzed to form free cholesterol 
esters that are cycled through the sarcolemma and internal membranes [104]. Due to the 
higher cholesterol content of cellular membranes compared to the cytoplasm, the 
transport and induction of cholesterol into membranes occurs along a step gradient, and 
requires active transport. An exact mechanism of intracellular cholesterol trafficking is 
currently unknown, however there is evidence for both vesicular and non-vesicular 
transport mechanisms [106]. 
 
Caveolae Composition, 
Structure, and Cellular 
Location 
In eukaryotic 
cells cholesterol-rich 
microdomains host the 
majority of receptors 
and membrane-bound 
components of growth 
signaling pathways, like 
that of insulin, and FGF 
[19]. Cholesterol exists within these domains among the fatty acid chain tails of the 
phospholipids, or the hydrophobic region of the membrane [19], and serves to provide 
Figure	4:	Membrane	Composition		
		
35	
35	
structural support for membranes [107], decrease membrane fluidity [24], and increase 
membrane ordering among transmembrane or membrane-bound proteins [108].  
These cholesterol-rich microdomains are categorized as either lipid rafts or 
caveolae. Lipid rafts are flat domains, while caveolae are small invaginations structurally 
dependent on the cholesterol-binding protein caveolin [19]. In skeletal muscle the 
isoform caveolin-3 is critically important for maintaining caveolae structure, as caveolin-
3 knockout models show an absence of caveolae [109, 110], T-Tubule dysfunction, 
altered distribution of the dystrophin glycoprotein complex [109, 111], and muscle 
degeneration [111]. 
These cholesterol-rich microdomains exist within the sarcolemma as well as 
internal organelle membranes such as the sarcolamic reticulum membrane system. 
Evidence demonstrates that reduced membrane cholesterol within sarcolemma 
microdomains weakens the myofiber membrane and decreases membrane order [97], 
while increased cholesterol decreases membrane fluidity but leaves it rigid and 
susceptible to exercise-induced damage [25, 97]. These fluid and rigid states are termed 
either gel or liquid ‘phases’, and depend on the type of phospholipid, the saturation of the 
phospholipid fatty acid chain tail, and the amount of cholesterol with the membrane [97]. 
These biophysical properties can be measured quantitatively through determining a 
Young’s Modulus value, or specific to cell membranes, the elastic modulus. Multiple 
normal cell functions have been linked to these modulus values, including phagocytosis 
in macrophages [112] and ABCA1-mediated cholesterol efflux in hamster kidney cell 
[113].  
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The composition of caveolae includes cholesterol, and glycerine- and ceramide- 
based phospholipids. Glycerophospholipids are unsaturated fatty acids with double bonds 
between the carbons along their fatty acid chain [97, 114]. These double bonds create 
‘kinks’, or bends in the fatty acid chain tails of phospholipids that take up more space 
with the phospholipid bilayer, thereby decreasing membrane density, rigidity, and 
increasing fluidity. Glycerine based phospholipids include phosphotitidylcholine (PC), 
phosphotitylethanolamine (PE), and phosphatidylserine (PS), and phosphotityleinositol 
(PI). Phosphotitylcholine is the most abundant phospholipid in most biological membrane 
systems, representing roughly 50% of all phospholipids within most membrane systems 
[115]. However, lipid rafts and caveolae have a particularly low concentration of 
glycerophospholipids compared to the rest of the membrane, while ceramide based 
phospholipids are more concentrated in these microdomains [19]. These microdomains 
host a myriad of cell regulatory signaling molecules and therefore require a highly 
ordered, stable, but fluid membrane. Ceramide-based sphingolipids provide this stability 
because of the biochemical structure of their fatty acid chain tails. 
Cholesterol preferentially associates with the ceramide-based phospholipid 
sphingomyelin [97, 114, 116], which are long chained saturated fatty acids with an 
absence of double bonds along their carbon chains. The absence of double bonds means 
there are no ‘kinks’ in the fatty acid chain, the molecule itself is more evenly cylindrical, 
and they can therefore be packaged much more tightly within the membrane. Tight 
packaging of sphingomyelin increases membrane order within these domains, but 
decreases membrane fluidity, keeping the membrane region in a solid ‘gel’ phase. The 
addition of cholesterol between the fatty acid chains of sphingolipids serves to fluidize 
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solid phase membrane regions into a ‘liquid-ordered’ state by keeping fatty acid chain 
tails of phospholipids ordered, but also allowing lateral diffusion of membrane 
components [97, 114].  
Caveolae are particularly concentrated within the Travers-Tubule (T-Tubule) 
system of the myofiber, however cholesterol and caveolin-3 anchored microdomains are 
also found in the SR membrane of skeletal muscle fibers, independent of the RYRY and 
DHPR [85, 117], and have been shown to primarily exist within these internal membrane 
structures of skeletal muscles in both humans and rodents [117]. The SR membrane 
harbors the sarcoendoplasmic reticulum calcium ATPase (SERCA) pumps responsible 
for pumping calcium back into the SR membrane system after a muscle contraction. The 
function of SERCA pumps in the SR membrane directly affects GLUT4 translocation 
through regulation of Ca+ in rodent myocardium [118, 119] and cardiomyocytes [120]. 
 
Cholesterol and GSV Membrane Fusion 
 Vesicle membrane fusion to the sarcolemma is dependent on SNARE proteins, a 
class of membrane proteins responsible for cellular membrane-membrane fusion events 
discussed previously in this chapter. IN the specific case of skeletal muscle, SNARE 
proteins are responsible for opening the initial fusion pore and connecting the membranes 
of the sarcolemma and the GSV [121], while cholesterol has been observed to directly 
affect this process [122-129]. Cholesterol has been shown to lower the activation energy 
of SNARE-mediated pore formation [128]. A second way in which cholesterol has been 
observed to affect fusion is through altering the orientation of the SNARE protein motifs 
within the membrane. Tong et al demonstrated that the synaptobrevin TM domain was 
		
38	
38	
tilted when reconstituted membranes lacked cholesterol, and became perpendicular after 
the addition of cholesterol, which coincided with increased membrane fusion [129] 
suggesting that membrane cholesterol content has a direct impact on the efficiency of 
GSV tethering and fusion with the sarcolemma membrane during GLUT4 translocation 
due to steric influences on SNARE proteins embedded in the membrane.  
 
Cholesterol and Insulin Resistance 
While cellular mechanisms involved in the etiology of hyperglycemia- and 
hyperinsulinemia-induced insulin resistance have been described, increases in either SL 
or SR membrane cholesterol may also contribute. Evidence to support this contention 
comes from a strong association between hypercholesterolemia/ hypertriglyceridemia and 
insulin resistance, an association between hypercholesterolemia and increased 
sarcolemma cholesterol content, and an association between membrane cholesterol and 
insulin resistance. However it has never been specifically demonstrated that increased 
membrane cholesterol content in skeletal muscle fibers inhibits insulin-stimulated 
glucose uptake.  
Bonora et al. demonstrated the prevalence of insulin resistance in various 
metabolic disorders and found insulin resistance to be present in 53% of all 
hypercholerolemia patients, 84.2% of hypertriglyceridemia patients, and 88% of subjects 
with low HDL [32]. The prevalence of insulin resistance in subjects with low HDL is 
important to note given how cholesterol is processed; cholesterol is first packaged as 
LDL, absorbed and used by the cell, then expelled as HDL. Therefore, low HDL means 
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that cholesterol is not being expelled from the cell, and potentially accumulating in the 
membranes.  
As discussed earlier in this chapter, Ca2+ has a distinct role in GSV translocation, 
docking and fusion through CaMK, AMPK, AS160, Kv1.3, SVII, and SNARE proteins 
[78, 79, 85, 87, 95], while cholesterol has been demonstrated to affect Ca2+ mediated 
vesicle fusion and reuptake of calcium back into the SR during E-C coupling [87].  The 
precise mechanism of cholesterol-induced changes in sarcoplasmic [Ca2+] is currently 
unclear, but due to the sensitivity of GSV fusion to changes in [Ca2+], and the role of Ca2+ 
in translocation and docking, cholesterol may also affect GSV translocation through a 
Ca2+ dependent mechanism as well.  
 
Cholesterol and Membrane-Membrane Fusion 
Membrane fusion between GSVs and cell membranes is inhibited in insulin 
resistant human adipose cells, despite insulin-stimulated GSV clustering at the plasma 
membrane of the adipocyte [130, 131]. While increased cholesterol membrane content 
may impact myofber glucose uptake by inhibiting the overall insulin signaling pathway at 
a variety of potential sites and through a variety of molecular signals, based on this 
observation it seems more likely that the primary site of disruption involves GLUT4 
translocation, specifically GSV docking and fusion with the sarcolemma, One possible 
explanation for this disruption may be that a differential cholesterol content between the 
GSV membrane and the site of GSV fusion in the sarcolemma, leads to inhibition of this 
specific step in insulin-stimulated glucose uptake. For example, Garvey et al. provided 
evidence that in insulin resistant and diabetic individuals, GLUT4 was packed into more 
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dense membrane vesicles, and that GLUT4 translocation was inhibited in these 
individuals [132]. Breisblatt et al. found that the addition of cholesterol (33% by weight) 
to artificial bilayer membranes inhibited fusion between membranes, as well as altered 
optimal fusion temperatures [133]. Further, Koga et al. found that either removing 
cholesterol of mouse liver cells using methyl-β-cyclodextrin in vitro, or increasing 
membrane cholesterol by high-fat diet in vivo, suppressed autophagic vesicular fusion by 
as much as 70% [134]. While it is unclear whether overall increased membrane 
cholesterol content per se, or specifically differential cholesterol content between the two 
fusing membranes results in this inhibition, there is no doubt that cholesterol content is an 
important modulator of membrane-membrane fusion events in general.  
 
Membrane Cholesterol and Insulin-Stimulated Glucose Uptake  
Animal Models  
Altering membrane cholesterol can be done in vivo through high fat diet [1, 2, 
25], which coincides with insulin resistance [1, 2]. Lianos et al. demonstrated this 
increased membrane cholesterol to be found specifically in the T-tubule of mice fed a 
high fat diet [2]. Habegger et al. found the same intervention in mice to cause a loss of F-
actin and dysfunction in GLUT4 vesicle transport [1]. Knoblauch et al. found that an 
increase in membrane cholesterol in hypercholesteremic mice coincided with increased 
sarcolemma damage following exercise [25], suggesting that the membrane-membrane 
fusion process essential for repair of exercise-induced membrane damage is inhibited in 
these animals. Conversely, it has also been demonstrated that lowering membrane 
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cholesterol using methyl-β-cyclodextrin (MβC) increases GLUT4-dependent glucose 
uptake and reduces insulin resistance in obese mice [2].  
Cholesterol is most abundant in skeletal muscle tissue with in the membrane of 
the SR [117] and can independently affect GSV translocation intermediates. Increased 
cholesterol content in the SR membrane has been shown to physically inhibit SERCA 
rotational mobility in rabbit skeletal muscle, in turn affecting cytoplasmic [Ca2+] [135]. 
However, it has never been directly observed in animal models that increased myofiber 
SL or SR membrane cholesterol content directly affects insulin signaling or glucose 
uptake. The major limitation with in vivo models of hypercholesterolemia, altered 
membrane cholesterol, and insulin resistance is the difficulty in proving causality. 
 
Cellular Models  
The effect of altered sarcolemma membrane cholesterol content on insulin 
stimulation has been studied extensively in 3T3-L1 adipocytes. Cholesterol depletion has 
been shown to inhibit IR autophophorylation, IRS-1 phosphorylation, glucose uptake, 
and activation of the PKB/Akt pathway [33-36]. These studies demonstrate the 
importance of cholesterol regarding insulin-stimulated glucose uptake, however 
decreased but not depleted cholesterol content via chromium has been shown to increase 
insulin-stimulated GLUT4 translocation and glucose uptake [37]. For internal 
membranes, cholesterol enrichment increases [Ca+]I while cholesterol depletion 
diminished [Ca+], a commonality among several cell lines [136]. The effect of altered 
cholesterol content in the SR membrane on insulin-stimulated glucose uptake however, 
has never been observed.  
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It is important to remember that the major recipient of insulin’s effects in vivo is 
skeletal muscle while the majority of research on insulin-stimulated GLUT4 translocation 
and glucose uptake in vitro has been in adipocytes [13, 18, 19]. Further, caveolae 
membrane components can be cell and species specific [19] and therefore studying such 
signaling pathways in adipocytes may not accurately represent normal in vivo responses 
to hypercholesterolemia in general, or in skeletal muscle specifically. Considering 
skeletal muscle is the organ most responsible for glucose deposition out of circulation, an 
in vitro model that most closely resembles a functional skeletal muscle fiber would be 
better suited for investigating molecular mechanisms of insulin-stimulated glucose 
uptake. 
 
Experimental Challenges 
3T3-L1 adipocytes have also been used extensively to characterize insulin-
stimulated GLUT4 translocation, glucose uptake, and altered membrane cholesterol 
content [13, 18, 19]. However, since skeletal muscle is the predominant tissue for glucose 
utilization an optimal cellular model of insulin-stimulated glucose uptake in skeletal 
muscle is critical for understanding whole body glucose homeostasis and our ability to 
treat its deregulation. The mouse C2C12 and rat L6 skeletal muscle-derived cell lines 
have been used previously for this purpose [12, 38-45, 137, 138]. The L6 cell line has 
been successfully used in the past to investigate insulin-stimulated GLUT4 translocation 
and glucose uptake [46], however L6 myotubes lack sarcomere formation and the 
potential for contractile activity [47, 48]. The C2C12 cell line has had mixed results 
regarding insulin-stimulated GLUT4 translocation and glucose uptake. Some researchers 
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have found little to no glucose uptake response to insulin-stimulation [12, 44, 50, 139], 
while few have described successful protocols for insulin stimulated glucose uptake [43] 
and GLUT4 translocation [39]. The C2C12 cell line however does effectively forms 
sarcomeres and develops contractile potential [47, 49]. Considering the complicated 
interweaving network of insulin- and contraction-induced signaling pathways mediating 
GLUT4 translocation, a detailed and reproducible cellular model of insulin-stimulated 
glucose uptake in a C2C12 myotube culture would provide significant opportunities to 
more fully investigate the underlying cellular mechanisms involved in normal insulin-
stimulated skeletal muscle glucose uptake and the etiology of various environmental 
conditions leading to pathologies such as insuline resistance and Type II diabetes.  
Interestingly, much of the literature investigating insulin stimulated glucose 
uptake includes only high-glucose medium conditions up until the glucose uptake 
measurements are performed, or does not list the glucose concentrations in which these 
cells were cultured at all [12, 38, 50, 139]. The concentration of standard high glucose 
tissue culture medium is 25mM (450mg/dL), far greater than the low-glucose variety at 
5.5mM (99mg/dL), which approaches the normal circulating levels of blood glucose at 
70-100mg/dL in healthy individuals. A few researchers have demonstrated that 
incubation in high-glucose culture medium causes insulin resistance [31, 43]. Leonitieva 
et al. demonstrated impaired insulin-stimulated Akt phosphorylation in C2C12 myoblasts 
and impaired glucose uptake in retinal pigment epithelial (RPE) cells when using high 
glucose tissue culture medium, while 42-44h in low glucose tissue culture medium 
restored insulin sensitivity [31]. Nedachi et al. observed that high glucose content 
impaired insulin-stimulated 2-deoxy glucose (2DG) uptake within only 5 minutes of 
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exposure [43]. Therefore, it is quite possible that currently much of the literature may be 
describing tissue cultures models that reflect hyperglycemia-induced insulin resistance 
rather than normal glucose uptake, especially considering the lack of an insulin response 
found by many researchers in a range of cell types. As such, when developing an 
appropriate tissue culture model for investigating insulin-stimulated glucose uptake in 
skeletal muscle tissue not only is the choice of cell type and degree of cell differentiation 
going to be important, but so too will be the impact of culture conditions, especially 
selection of glucose medium concentrations. 
 
Summary 
Hypercholesterolemia from diet or physical inactivity may contribute to insulin 
resistance by increasing membrane cholesterol content in skeletal muscle fibers. Altered 
cholesterol content in the outer membrane has been shown to affect GLUT4 
translocation-mediating pathways in vitro using adipocytes, while animal and human 
models suggest a strong association between hypercholesterolemia, increased membrane 
cholesterol, and insulin resistance. The direct effect of increased membrane cholesterol 
content on insulin-stimulated glucose uptake has yet to be fully investigated using a 
reproducible and consistent model of skeletal muscle. Further, much of the literature 
regarding insulin-stimulated glucose uptake in tissue culture models describe utilizing 
high concentrations of glucose in the culture media, conditions that may unknowingly be 
causing insulin-resistance in these cultured cells. Therefore the aim of this study is to 
develop a reliable model to study insulin-stimulated glucose uptake under physiologically 
normal glycemic conditions in differentiated C2C12 myotubes, and use this model to 
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investigate the effect of altered membrane cholesterol content on insulin-stimulated 
glucose uptake. 
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Chapter 3 – Materials and Methods 
Materials 
Cell Lines: 
The mouse C2C12 myocyte cell line was obtained from Sigma Aldrich (St. Louis, MO). 
Cells were initially expanded in tissue culture for three passages in culture to create a 
common pool of C2C12 myocyte cells (passage 3). This stock culture of C2C12 
myocytes was resuspended in 10% (v/v) fetal bovine serum (FBS) containing 10% 
dimethylsulphoxide (DMSO), aliquoted into cryovials and stored under liquid nitrogen. 
All subsequent experiments investigating glucose uptake in C2C12 myotubes utilized 
C2C12 myocytes from this stock culture that were passage 8 or below. 
 
Tissue Culture Medium Preparations: 
Basal C2C12 tissue culture media consisted of Dulbecco’s Modified Eagle’s Media 
(DMEM) containing either 4.5g/L (25mM, 450mg/dL) (i.e. high glucose) or 1g/L 
(5.5mM, 100mg/dL) (i.e. low glucose) of glucose, Glutamax™ supplement, 25mM 4-(2-
Hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), 1mM pyruvate (Thermofisher, 
Waltham MA), and 4mM L-Glutamine. Both high glucose basal tissue culture medium 
(HG-DMEM) and low glucose basal tissue culture medium (LG-DMEM) contained 100 
mM of both penicillin and streptomycin  (Thermofisher, Waltham MA). 
 
C2C12 growth medium consisted of HG-DMEM containing 10% (v/v) fetal bovine serum 
(FBS) (10%FBS.HG-DMEM). FBS was obtained from Thermofisher (certified US 
origin, Waltham, MA). 
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C2C12 differentiation medium consisted of either HG-DMEM containing 2% (v/v) heat 
inactivated horse serum (HS) (2%HS.HG-DMEM) or LG-DMEM containing 2% (v/v) 
HS (2%HS.LG-DMEM). Heat inactivated HS was obtained from Thermofisher (certified 
US origin, Waltham, MA). 
 
C2C12 Serum Starvation medium consisted of LG-DMEM (Thermofisher, Waltham MA) 
containing 1% (w/v) filter sterilized, purified bovine serum albumin (BSA) 
(Thermofisher, Waltham MA) and 100mM penicillin and streptomycin (1%BSA.LG-
DMEM). 
 
Glucose uptake assay media consisted of glucose-free Dulbecco’s Modified Eagle’s 
Media (DMEM). 
 
Tissue Culture Plates: 
Standard T75 cell culture flasks (VWR, Radnor, PA) were used to expand C2C12 
myocytes in tissue culture for use in subsequent experiments. 6-well tissue culture treated 
plates (VWR, Radnor, PA) were used for all experiments involving subsequent imaging, 
while 96-well tissue culture-treated plates optimized for fluorometric assays were used 
for glucose uptake, total protein and total cholesterol measurements (VWR, Radnor, PA). 
 
Tissue Culture Reagents: 
Dulbecco’s Modified Phosphate buffered saline (DPBS-) (Sigma Aldrich, St. Louis MO, 
St. Louis MO), or DPBS+ containing 1mM calcium and 1mM magnesium (DPBS+) 
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(Thermofisher, Waltham MA) and 0.05% (w/v) trypsin EDTA solution (Sigma Aldrich, 
St. Louis, MO) were used for subculture of C2C12 cells. Porcine gel solution (used for 
coating of tissue culture plates in which C2C12 myoblasts were differentiated into 
myotubes) consisted of a sterilized aqueous solution made up of deionized water 
containing 1% (w/v) porcine gel (Sigma Aldrich, St. Louis MO). 
 
Cell Labeling Reagents: 
2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-Deoxyglucose, a 
fluorescent, analog of glucose (2-NBDG) (Molecular Probes), was used to quantify either 
basal or insulin-stimulated glucose uptake into differentiated C2C12 myotubes. 
 
Purified insulin from bovine pancreas (Sigma Aldrich, St. Louis MO, St. Louis MO) was 
used to stimulate insulin-stimulated glucose uptake into differentiated C2C12 myotubes.  
 
A fluorescently labeled analog of cholesterol, 23-(dipyrrometheneboron difluoride)-24-
norcholesterol (Fluorescent Cholesterol Analog – FCA) (Avanti Lipids, Alabaster Al), 
was used to determine the initial experimental time course required to selectively enrich 
either the external or internal membranes of differentiated C2C12 myotubes with native 
cholesterol in culture. 
 
Water-soluble cholesterol (WSC) (Sigma Aldrich, St. Louis MO, St. Louis MO) 
consisting of a cholesterol/methyl-β-cyclodextrin complex dissolved in tissue culture 
medium was used to selectively enrich either the external or internal membranes of 
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differentiated C2C12 myotubes with native cholesterol in culture prior to determining 
glucose uptake using 2-NBDG. Methyl-β-cyclodextrin (MβC) alone, dissolved in tissue 
culture medium, was used to selectively deplete native cholesterol from the membranes 
of differentiated C2C12 myotubes in culture prior to determining glucose uptake using 2-
NBDG. 
 
Immunohistochemical Reagents: 
A skeletal muscle sarcomeric myosin heavy chain (MHC) mouse monoclonal IgG 
antibody was obtained from the Developmental Studies Hybridoma Bank (Iowa City, 
Iowa). A biotinylated anti-mouse peroxidase ABC detection kit was obtained from 
ABCAM (Cambridge United Kingdom).  A dihydropyridine (DHP) receptor channel 
mouse monoclonal IgG1 primary antibody was obtained from (Thermo Scientific, 
Waltham Ma), and used in conjunction with a goat anti-mouse IgG1 AlexaFluor™ 647 
obtained from Life Technologies (Carlsbad, CA). Heat-inactivated goat serum (HIGS), 
ammonium chloride and Triton X-100 (TX-100) were obtained from Sigma-Aldrich (St. 
Louis, MO). Dulbecco’s Phosphate Buffered Saline (D-PBS) was obtained from Fisher 
Scientific (Hampton, NH). D-PBS was used either without calcium and magnesium (D-
PBS-) or with 1mM calcium and magnesium (D-PBS+). 
 
Methods 
C2C12 Myoblast Culture: 
 Stock cultures of C2C12 myoblasts were removed from storage under liquid 
nitrogen and grown in T75 cell culture flasks using 10%FBS.HG-DMEM growth media 
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at an initial density of 2000 cells/cm2. C2C12 myoblasts were cultured in a humidified, 
tissue culture incubator at 37oC, in a 5% (v/v) CO2 atmosphere. Once myoblasts reached 
approximately 60% confluence by visual inspection they were sub-cultured into a new 
T75 flask for further myocyte expansion, with a sub-set of cells being plated into either 6 
or 96-well tissue culture plates for differentiation and subsequent experimentation. The 
remaining C2C12 myocytes were resuspended in FBS containing 10% 
dimethylsulphoxide (DMSO), aliquoted into cryovials and stored under liquid nitrogen to 
replenish C2C12 stock culture stores.  	 To subculture C2C12 myoblasts, growth media was removed from the cell 
monolayer and washed with two changes of sterile DPBS- for a total of two minutes. 
DPBS was removed and cells were incubated with 15mL of 0.05% trypsin/EDTA 
solution at 37oC until the cells had detached from the flask. The cell suspension was then 
mixed 1:1 with growth media containing FBS in order to neutralize the trypsin. The cell 
suspension was then decanted from the tissue culture flask into sterile, 50 ml centrifuge 
tubes and centrifuged for 5 minutes at 100xg. The cell pellet was then resuspended into a 
single cell suspension by titurating the cell pellet in 5 ml of standard growth medium 
using a sterile 1ml pipette tip. The number of cells in the cell suspension was counted 
using a hemocytometer and then diluted to the desired cell density with fresh standard 
growth medium for subsequent sub-culture and/or experimentation.  
 
Coating Cell Culture Plates in Porcine Gel for Subsequent Myotube Formation 
C2C12 myotubes cultures were grown and differentiated in tissue culture-treated, 
non-pyrogenic 6-well or 96-well polystyrene plates. To provide additional adherence to 
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the culture surface, culture plates were coated with a porcine gel solution prior to cell 
seeding. Culture plates were first incubated for 1 hour at 37oC in the porcine gel coating 
solution, followed by 3 washes with sterile deionized water and one wash with sterile 
DPBS-. Each well was aspirated to dryness prior to being seeded with C2C12 myoblasts 
at a known cell density.  
 
C2C12 Myotube Differentiation: 
Preliminary observations indicated that continuous culture and expansion of 
C2C12 myocytes beyond passage 10 in high glucose DMEM growth medium appeared to 
reduce the rate and subsequent degree of myotube differentiation that could be achieved 
in culture. As such, all experiments utilizing differentiated C2C12 myotube cultures were 
derived from C2C12 myocytes cultured for no more than 8 passages beyond the original 
myocyte cell line obtained from Sigma Aldrich (St. Louis, MO). 
C2C12 myoblasts (below passage 8) were suspended in 10%FBS.HG-DMEM and 
seeded into either 6- or 96-well porcine gel-coated culture plates at a density of 10,000 
cells/cm2 of culture surface. Cells were grown for three days until the wells of each plate 
appeared by visual observation to be approximately ≥90% confluent. Once the cultures 
had reached ≥90% confluence, 10%FBS.HG-DMEM growth medium was replaced with 
2%HS.LG-DMEM differentiation medium. 2%HS.LG-DMEM differentiation medium 
was exchanged for fresh differentiation medium every other day for 6 days. Formation of 
C2C12 myotubes was determined both visually, as determined by the formation of three 
dimensional myotubes structures in the culture, as well as subsequent verification of 
myotube differentiation by detection of myosin heavy chain (MHC) expression and 
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dihydropyridine (DHP) receptor expression using immunohistochemistry (IHC), both 
markers of terminal differentiation in skeletal muscle myofibers in vivo [140-144].  
 
Skeletal Muscle Myosin Heavy Chain (MHC) Peroxidase Immunohistochemistry 
C2C12 myotubes grown in 6-well tissue plates were first washed with two 
changes of D-PBS+, fixed and permeabilized in ice-cold methanol for 2 minutes, and 
washed again with two changes of DPBS+. The fixed myotubes were then incubated in 
4% heat-inactivated goat serum in DPBS+ for 1 hour to block non-specific protein 
interactions prior to sarcomeric MHC primary antibody exposure. Samples were 
incubated overnight at 4oC with a mouse polyclonal IgG primary hybridoma antibody 
specific to sarcomeric myosin heavy chain (MHC) at a concentration of 10ug/mL in 
DPBS+, supplemented with 1% HIGS to inhibit non-specific protein interaction. The 
following day myotube samples were washed a total of four times over 20 minutes using 
DPBS+, followed by detection of MHC primary antibody binding using a biotinylated 
goat-anti-mouse IgG secondary antibody coupled to horse-radish peroxidase (Abcam, 
Cambridge UK) as per the manufacturer’s instructions. Skeletal muscle sarcomeric MHC 
peroxidase staining of myotubes was imaged under bright-field conditions using a light 
microscope (Olympus, Tokyo, Japan). To determine non-specific secondary antibody 
binding, parallel myotube cultures were subjected to the same immunocytochemistry 
protocol in the absence of the primary antibody. 
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Dihydropyridine (DHP) Receptor Fluorescent Immunohistochemistry 
 Myotubes in 6-welled plates were first fixed in 1% paraformaldehyde for 5 
minutes then washed 3 times with DPBS+. Myotubes were then permeabilized using D-
PBS+ containing 1% (v/v) TX-100 for 5 minutes and washed three times with DPBS+. 
Samples were then incubated for 30 minutes in D-PBS+ containing 50mM ammonium 
chloride to inhibit non-specific fluorescent signal followed by another three washes in 
DBPS+. Samples were incubated for 1 hour in D-PBS+ containing 4% HIGS to inhibit 
non-specific protein interactions followed by overnight incubation with a primary mouse 
anti-DHP IgG1 antibody diluted to 1:400 with D-PBS+ containing 1% (v/v) HIGS at 4oC. 
The samples were washed using 5 changes of D-PBS+ and then incubated for 2 hours at 
room temperature with secondary antibody consisting of an Alexa Fluor™ 647-
conjugated goat anti-mouse IgG1 secondary antibody (10mg/ml) diluted in D-PBS+ 
containing 1% (v/v) HIGS. Samples grown in 6-well plates were then washed three 
changes of DBPS+ over 5 min, aspirated to dryness, mounted in Fluoromount G, cover-
slipped and then sealed.  Mounted and sealed samples were excised from the plate with a 
blowtorch-heated scalpel as described in further detail later in this section in preparation 
for confocal microscopy analysis. Samples were imaged using excitation and emission 
wave-lengths of 647nm and 720nm, respectively. Since the emission wavelength of the 
Alexa™ 647nm fluorophore is beyond the visible light spectrum, fluorescent signal 
associated with secondary antibody binding was assigned a light blue color using the 
imaging software. 
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Basal and Insulin-Stimulated Glucose Uptake Measurements in C2C12 Myotubes 
A fluorescent glucose analog, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-
yl)Amino)-2-Deoxyglucose (2-NBDG), a non-metabolizeable form of glucose, was 
used to determine glucose uptake under basal and insulin-stimulated conditions in 
differentiated C2C12 myotube cultures. A concentrated, stock 2-NBDG solution was 
prepared by dissolving 1mG of 2-NBDG powder in 1mL of serum-free, glucose-free 
DMEM medium which was then aliquoted and stored at -20oC for future experiments.  
Previous studies have suggested that differentiated C2C12 myotubes cultured in 
high glucose medium appear to exhibit insulin insensitivity and reduced insulin-
stimulated uptake of glucose as compared to myotubes cultured in low glucose medium 
[31, 43]. In order to test whether or not high glucose culture conditions induced insulin 
insensitivity in the C2C12 myotubes utilized in this study, the effects of culturing 
differentiated C2C12 myotubes in high or low glucose differentiation medium for a 
period of two days prior to measuring glucose uptake was tested. As can be seen in Table 
1, high glucose differentiation culture conditions did not have any discernible effect on 
the basal (i.e. GLUT1-mediated) uptake of glucose in differentiated C2C12 myotubes. 
However, exposure of C2C12 myotubes to low glucose culture conditions for a period of 
48 hours prior to stimulation of the C2C12 myotubes with insulin caused a reproducible 
though not statistically significant increase in the amount of insulin-stimulated (i.e. 
GLUT4-mediated) glucose uptake.  
Based on these initial experimental observations, to ensure maximum insulin 
sensitivity all subsequent experiments investigating glucose uptake utilized differentiated 
C2C12 myotubes incubated in low glucose differentiation medium for 48 hours prior to 
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testing. In addition, in order to negate the effects of insulin and other insulin-like growth 
factors that may be constitutively present in the serum fraction of the low glucose 
differentiation medium, 16 hours prior to testing C2C12 myotubes were washed with 
warm D-PBS+ to remove any serum components and then cultured in low glucose 
differentiation medium containing 1% (w/v) purified BSA as a serum substitute. The 
experimental tissue culture protocol and timeline for generating differentiated C2C12 
myotube cultures used in subsequent glucose uptake experiments is depicted graphically 
below in Figure 5. 
 
Figure 5: Experimental Time Course for Differentiation and Subsequent Testing of 
Glucose Uptake In C2C12 Myotubes 
 
In order to determine basal (i.e. GLUT1-mediated) or insulin stimulated (i.e. 
GLUT4-mediated) glucose uptake, differentiated C2C12 myotube cultures in either 6-
well or 96-well plates were first washed with warm D-PBS+ and then incubated for 30 
minutes in a reaction buffer consisting of warm, glucose-free, serum-free DMEM 
containing 400µM 2-NBDG and either 0nm (basal uptake conditions), 10nM, 25nM, 
50nM or 100nM insulin, respectively. The glucose uptake assay was carried out in the 
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dark at 37oC in a tissue culture incubator. Labelled C2C12 myotubes were then washed 
with ice-cold DPBS+ and aspirated to dryness to remove any free 2-NBDG remaining in 
each well. 
Labeled C2C12 myotubes in 6-welled plates were mounted in Fluormount G 
(Electronic Microscopy Sciences), cover-slipped and then immediately imaged under an 
epifluorescent microscope (Olympus) to visualize the uptake of the fluorescent glucose 
analog (2-NBDG) into myotubes (Figure 3). Alternatively, C2C12 myotubes assayed for 
glucose uptake in 96-well plates were immediately lysed in 100 microliters of ice-cold 
lysis buffer containing 0.1M potassium phosphate and 1% (v/v) Triton X-100 adjusted to 
pH 10 to release the fluorescent glucose analog (2-NBDG) taken up by the myotubes. 
The amount of 2-NBDG taken up by C2C12 myotube cultures in each well was 
quantified using a fluorometric plate reader (Thermofisher, Waltham MA) using an 
excitation wavelength of 468 nm and an emission wavelength of 540 nm. After 
measuring the fluorescent signal in the lysate of each well, a portion (10 microliters) of 
the lysate removed from each C2C12 myotube culture was analyzed for total protein 
content using a BCA protein assay kit (Thermofisher, Waltham MA). Glucose analog (2-
NBDG) uptake (in fluorescent units - FU) per C2C12 myotube culture was reported as 
FU/mg total protein in order to normalize for any differences in the number of C2C12 
myotubes present in each culture. In those experiments designed to investigate the effects 
of selective enrichment or depletion of C2C12 myotube membranes with cholesterol on 
glucose uptake, a separate portion of the lysate (10 microliters) was also analyzed for 
cholesterol content using a total cholesterol assay kit (Pointe Scientific, Canton, MI).  
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Cholesterol Localization in C2C12 Myotubes Under Different Pulse-Chase Labelling 
Conditions 
In order to achieve selective enrichment of internal and external C2C12 myotube 
membranes with cholesterol, the time course for cholesterol trafficking in tissue culture 
under specific pulse-chase enrichment conditions was investigated. The time course of 
cholesterol trafficking between the tissue culture medium and its subsequent localization 
in specific myotube membrane structures was initially determined using a fluorescent 
analog of cholesterol, 23-(dipyrrometheneboron difluoride)-24-norcholesterol. While 
slightly larger than native cholesterol, when introduced to serum-containing tissue culture 
medium this fluorescent analog has previously been shown to be taken up and 
subsequently distributed within tissue cultured cell membranes in a similar manner to 
native cholesterol [145, 146]. 
Cholesterol and fluorescent cholesterol analogs are normally insoluble under 
aqueous conditions. In biological systems, cholesterol is transported in the blood or 
interstitial fluid complexed to carrier proteins such as low density lipoproteins (LDL). 
These carrier proteins transport the cholesterol to the external cell membranes where the 
cholesterol is taken up into the cell via the LDL receptor.  As such, in order to introduce 
the hydrophobic fluorescent cholesterol analog molecule to C2C12 myotubes in culture, 
it must first be fully dissolved in pure ethanol prior to being subsequently diluted in 
serum-containing tissue culture medium. 
23-(dipyrrometheneboron difluoride)-24-norcholesterol (fluorescent cholesterol 
analog) was initially reconstituted at a concentration of 2g/mL in pure ethanol, sonicated 
to ensure efficient mixing, aliquoted into smaller amounts and stored in the dark at 4oC 
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for future experiments. Immediately prior to being added to serum-containing tissue 
culture medium, the stock analog solution was centrifuged at 10,000xg to remove any 
remaining undissolved material. Differentiated C2C12 myotubes growing in 6-well plates 
were cultured for 4 hours in standard differentiation medium containing different 
amounts of fluorescent cholesterol analog. After a defined period of exposure to the 
analog in culture, referred to as the initial “pulse” period, the C2C12 myotubes were 
washed with three changes of warm D-PBS+ and then fixed using D-PBS+ containing 
1% (v/v) paraformaldehyde (Electron Microscopy Sciences) for 10 minutes at room 
temperature. Fixative solution was removed from the sample by washing with D-PBS+, 
mounted in Fluoromount G (Electron Microscopy Sciences), cover-slipped with a 24mm 
X 24mm square coverslip and then sealed with sealant. Fluorescent laser scanning 
confocal microscopy (Leica Scanning Confocal Microscope) was used for subcellular 
membrane visualization of the fluorescent cholesterol analog. For optimal image 
acquisition, the mounted and sealed sample was excised from the base of 6-well plate as 
described later in this section. The fluorescent cholesterol analog was imaged using 
excitation and emission wavelengths of 468nm and 540nm, respectively. 
 The optimal concentration and the minimum “pulse” labeling times required to 
enrich specific C2C12 membranes with fluorescent cholesterol analog was initially 
determined using confocal microscopy. These experiments indicated that a 4 hour 
“pulse” labelling period at a final working concentration of 50 µM of fluorescent 
cholesterol analog resulted in the selective enrichment of the external sarcolemma and 
contiguous T-tubule membranes that could be clearly discerned by confocal microscopy 
(Figure 14). In addition, using a 4hr “pulse” label followed by a subsequent 16 hour 
		
59	
59	
“chase” period in standard differentiation medium absent the analog resulted in 
trafficking of the fluorescent cholesterol analog from the external sarcolemma/T-tubule 
membranes into the internal sarcoplasmic reticulum (SR) membrane system (Figure 14E 
and F). Furthermore, a 4hr “pulse” label and a 16 hour “chase” followed by an 
additional 4 hour “pulse” label resulted in significant enrichment of both external and 
internal membrane systems with the fluorescent cholesterol analog (Figure 14G and H). 
Data gained from these experiments were used to define the “pulse”/”chase” labeling 
conditions used to selectively enrich or deplete the external and internal membranes of 
C2C12 myotubes with native cholesterol in culture. 
 
Enrichment and Depletion of Cholesterol in C2C12 Myotube Membranes 
The cholesterol content in differentiated C2C12 myotube membranes was 
selectively altered using methyl-β -cyclodextrin (MβC), a cholesterol depletion 
approach previously used both in in vitro and in vivo studies [147]. Differentiated 
myotubes were enriched with native cholesterol in culture using a cholesterol / MβC 
complex known as Water-Soluble Cholesterol (WSC), or selectively depleted (external 
membranes) using MβC alone. As described above, a fluorescent cholesterol analog was 
used to experimentally define the “pulse”/”chase” labeling culture conditions 
subsequently used to selectively enrich or deplete the external and internal membranes of 
C2C12 myotubes with native cholesterol. As such, the sarcolemma/T-tubule membranes 
of differentiated C2C12 myotubes were selectively enriched with native cholesterol using 
a 4 hour “pulse” in serum-free differentiation medium (1%BSA.LG-DMEM) containing 
WSC at a final concentration of 200 µM cholesterol (the cholesterol / MβC complex is 
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prepared at a 1:23 ratio of cholesterol to MβC). Selective enrichment of the 
sarcoplasmic reticulum (SR) membranes of differentiated C2C12 myotubes with native 
cholesterol was achieved using a 4 hour “pulse” in medium containing WSC followed by 
a 16 “chase” in serum-free differentiation medium (1%BSA.LG-DMEM) alone. In 
addition, the sarcolemma/T-tubule membranes of differentiated C2C12 myotubes were 
selectively depleted of native cholesterol using a 4 hour incubation in serum-free 
differentiation medium (1%BSA.LG-DMEM) containing MβC alone at a final 
concentration of 4.6 mM, equivalent to the amount of MβC present in the 200 µM 
cholesterol/WSC complex. Enrichment and depletion of C2C12 myotube cultures, using 
WSC or MβC respectively, was chemically validated using a total cholesterol assay kit 
(Pointe Scientific, Canton, MI) after lysis of the treated myotubes cultures in lysis buffer 
containing 0.1M potassium phosphate and 1% (v/v) Triton X-100 adjusted to pH 10, the 
same lysis buffer utilized in glucose uptake assays. 
 
Laser-Scanning Confocal Microscopy 
  All C2C12 myotube samples analyzed using fluorescent scanning confocal 
microscopy were imaged using a Leica Scanning Confocal Microscope (Imaging Core 
Facility, University of Houston). In order to allow subsequent confocal microscopy 
imaging of C2C12 myotube samples grown and processed in 6-well tissue culture plates, 
the myotubes in each well were first mounted, cover-slipped and sealed and then excised 
from the base of the 6-well tissue culture plates using a blowtorch-heated scalpel as 
demonstrated in Figure 2. Samples analyzed to determine the subcellular localization of 
the fluorescent cholesterol analog, 23-(dipyrrometheneboron difluoride)-24-
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norcholesterol within C2C12 myotubes were imaged using excitation/emission 
wavelengths of 488 nm and 540 nm, respectively. In the case of samples analyzed to 
determine the subcellular localization of the dihydropyridine (DHP) receptor within 
C2C12 myotubes, the excitation/emission wavelengths used were 647 nm and 720 nm, 
respectively. Images were collected using arrange of magnifications (i.e. 20X dry lens, 
63X oil lens and 100X oil lens) and scale bars provide final dimensions in microns. 
Where noted, images were collected under identical imaging conditions to allow 
comparison of the fluorescent signal observed between experimental labelling conditions.  
 
Figure 6: Micrograph of a coverslip-mounted 
C2C12 myotube sample excised from the 
culture surface of a 6-well tissue culture plate. 
Coverslip-mounted C2C12 myotube cultures 
grown on the culture surface of 6-well tissue 
culture plates were excised using a blowtorch-
heated surgical scalpel in order for the sample to 
psychically fit the dimensions of the confocal microscope stage and allow the use of oil-
based, optical lenses for ultra-high power magnification imaging.  
 
Image Processing and Analysis 
  In order to obtain optimal spatial resolution of fluorescent cholesterol analog 
labelling of intracellular membrane components, or, specific fluorescent DHP antibody 
staining of T-tubule membranes, within individual C2C12 myotubes additional image 
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magnification and processing was performed. After initial confocal microscopy images of 
labelled C2C12 myotubes were acquired using a 100X magnification oil lens, specific 
regions of these images were electronically magnified by a factor of 300% using the 
Leica Confocal Microscopy Imaging Software. These electronically magnified images 
were then optimized using Huygens Deconvolution Software (Scientific Volume 
Imaging, Netherlands) to provide optimal spatial resolution of individual labelled 
membrane structures within the C2C12 myotube. 
 
Statistical Analysis 
  An initial 5x6-way (enrichment condition x insulin concentration) ANOVA 
assessed any between enrichment conditions. One-way ANOVAs were used to assess 
each enrichment group across all insulin concentrations, as well as the differences 
between enrichment conditions for each insulin concentration. One-way ANOVAs were 
also used to examine differences in total cholesterol and basal glucose uptake between 
enrichment conditions. Bonferroni post-hoc analyses were conducted in the event of any 
statistical significance being identified between conditions. Statistical significance was 
set at an alpha value of p = 0.05. 
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Chapter 4: Results 
The major cellular component of skeletal muscle tissue involved in glucose 
utilization in vivo is the myofiber.  This project set out to develop and characterize a 
reproducible tissue culture model of skeletal muscle myofibers in vivo in which to 
mechanistically investigate the cellular mechanisms involved in insulin-stimulated 
glucose uptake quantified using a fluorescent analog of glucose, 2-NBDG. In turn, this 
differentiated C2C12 myotube model was then be used to investigate the potential effects 
of selective cholesterol enrichment of specific membrane structures on insulin signaling 
and insulin-stimulated glucose uptake. 
 
Characterization of C2C12 Myotube Differentiation 
Differentiation of C2C12 myocytes seeded at a specific cell density and grown 
under defined tissue culture conditions for a set period of time was initially assessed 
based on the visual appearance of large, multinucleated fusiform cells in culture. The 
degree of myotube differentiation under these defined culture conditions was 
subsequently confirmed using immunohistochemical detection of myosin heavy chain 
(MHC) and dihydropiridine (DHP) receptor protein expression by these myotubes, both 
terminal differentiation markers of skeletal muscle myofibers in vivo [140].  The myotube 
differentiation process initiated under these defined culture conditions involves the 
appearance of numerous, large, multinucleated fusiform cells when the culture is exposed 
to heat-inactivated horse serum over a 6 day period. Formation and maturation of these 
myotubes can be observed in C2C12 myotube cultures at day 1, 4 and 6 of differentiation 
(Figure 7). 
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Figure 7: Representative Phase Contrast Micrographs of C2C12 Myotube Differentiation 
over The Course of 6 Days in Culture. Panel A illustrates the initial alignment and fusion 
of C2C12 myocytes into myotubes after 24hr in high glucose differentiation medium. 
Panel B illustrates the initial formation of large, morphologically distinct C2C12 
myotubes after 96 hours in high glucose differentiation medium. Panel C illustrates fully 
differentiated C2C12 myotube cultures after 144 hours of differentiation (96 hours in 
high glucose differentiation media followed by 48 hours of differentiation in low glucose 
medium).  
 
MHC protein expression by C2C12 myotubes after 6 days of differentiation in 
culture was confirmed using immunohistochemical staining using a mouse anti-myosin 
heavy chain (MHC) primary antibody followed by disclosure of primary antibody 
binding using an ABC immunoperoxidase staining kit and light microscopy (Figure 8). 
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Figure 8: Representative Micrographs of Sarcomeric Myosin Heavy Chain (MHC) 
Protein in Differentiated C2C12 Myotubes. C2C12 myotubes were differentiated for a 
total of six days, fixed in methanol and immunohistochemically stained for MHC protein 
disclosed using an immunoperoxidase secondary antibody kit. Panel A illustrates a low 
power light micrograph of MHC protein staining in large numbers of morphologically 
discrete, highly differentiated C2C12 myotubes in an individual myotube culture (Scale 
Bar – 200 µm). Panel B illustrates a high power light micrograph of MHC protein 
staining in an individual multi-nucleated, differentiated C2C12 myotube demonstrating 
the formation of myofibrils longitudinally orientated within the myotube (Scale Bar – 10 
µm).  
 
DHP receptor protein expression by C2C12 myotubes after 6 days of 
differentiation in culture was detected using a mouse anti-DHP primary antibody 
disclosed using a goat anti-mouse Alexa Fluor™ 647 fluorescent secondary antibody 
followed by confocal microscopy (Figure 9). 
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Figure 9: Representative Confocal Micrograph of Immunofluorescent DHP Receptor 
Staining In Differentiated C2C12 Myotubes. Image consists of a 1 µm thick optical 
section collected using a confocal microscope from a differentiated C2C12 myotube 
culture immunochemically stained for DHP receptor protein disclosed using an Alexa 
Fluor™ 647 fluorescent secondary antibody. (Scale Bar – 40 µm)   
 
The temporally predictable appearance of large, three-dimensional, multi-
nucleated myotubes coupled with the expression of both MHC and DHP receptor proteins 
demonstrate that the defined culture conditions developed in this study provide a highly 
reproducible means of generating large numbers of terminally-differentiated C2C12 
myotubes in culture at will. Apart from studying the effects of selective cholesterol 
membrane enrichment on insulin-stimulated glucose uptake which is the focus of the 
present study, this well-characterized in vitro tissue culture model of skeletal myofibers 
may prove useful for investigating a variety of other physiologically and pathologically 
relevant mechanisms operating in skeletal muscle in vivo. 
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Characterization of Insulin Stimulated Glucose Uptake using 2-NBDG in C2C12 
Myotubes. 
In order to ensure that any glucose uptake detected and quantified in differentiated 
C2C12 cultures using the fluorescent glucose analog, 2-NBDG, truly reflected either 
basal or insulin-stimulated glucose uptake by myotubes, the cellular localization of 2-
NBDG (Ex – 468nm, Em – 540nm) taken up by C2C12 myotube cultures was 
determined using epifluorescent microscopy. As can be seen in Figure 10, visual 
inspection of differentiated C2C12 myotube cultures exposed to 2-NBDG for 30 min in 
either the absence or the presence (i.e. 10nM insulin) using standard epifluorescent 
microscopy confirmed that the overwhelming majority of fluorescent 2-NBDG uptake 
was within the myotubes rather than by any unfused myocytes remaining in the culture 
(Figure 10). 
 
Figure 10: Representative Fluorescent Micrographs of 2-NBDG Uptake in Differentiated 
C2C12 Myotube Cultures. Panel A illustrates basal 2-NBDG uptake while Panel B 
illustrates 2-NBDG uptake in the presence of 10nm insulin. These images demonstrate 
that the overwhelming amount of 2-NBDG taken up during a 30 minute exposure in the 
absence (i.e. basal glucose uptake) or presence of 10 nM insulin (i.e. insulin stimulated 
glucose uptake) is accounted for by myotubes rather than any unfused C2C12 myocytes 
remaining in the culture. (Scale Bar – 500 µm).  
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 Initially, C2C12 myocytes and differentiated C2C12 myotubes where cultured in 
high glucose DMEM medium containing 25mM glucose, a concentration of glucose 
commonly used for culturing a variety of primary cells and established cell lines. 
However, physiologically speaking a circulating concentration of 25mM glucose 
(450mg/dL) is considered extremely hyperglycemic and potentially pathological if 
maintained over the long-term. Previous studies have demonstrated that even short-term 
incubation in tissue culture medium containing the high levels of glucose normally 
utilized in standard media preparations (25mM) appears to cause insulin resistance in a 
number of cultured cell types including skeletal muscle, with glucose uptake observed 
only after pre-incubation in low-glucose media (5.5mM or 100mg/dL glucose) [43]. 
In order to test the possibility that extended culture in high glucose conditions (i.e. 
25mM glucose) might have resulted in a blunted insulin stimulated glucose uptake 
response in differentiated C2C12 myotubes generated under the culture conditions 
developed in this study, insulin stimulated glucose uptake in response to 10nM insulin 
was compared between: (1) C2C12 myotubes differentiated for 6 days under high glucose 
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conditions (i.e. 25 mM glucose) alone; and (2) C2C12 myotubes differentiated for 4 days 
under high glucose conditions (i.e. 25mM glucose) followed by an additional two days 
under low glucose conditions (i.e. 5.5mM glucose, 100mg/dL) (Figure 11). 
 
Figure 11. The Effect of 48 Hours of Culture in Low Glucose Differentiation Media on 
Insulin Stimulated Glucose Uptake in C2C12 Myotubes. Insulin stimulation using 10nM 
insulin significantly increased glucose uptake in both conditions (* = p < 0.05). While 
culture in low glucose conditions increased insulin stimulated glucose uptake by 
approximately 20% compared to high glucose conditions, this increase was not found to 
be statistically significant. Glucose uptake per myotube culture was initially expressed as 
fluorescence units (FU)/(ug) of total protein and then normalized to the mean control 
value which was expressed as a value of one. Normalized values for glucose uptake for 
each condition were plotted as the mean +/- standard error. (N = 14 for each condition). 
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While there was no statistically significant difference in the amount of insulin 
stimulated glucose uptake detected between the two culture conditions described in 
Figure 11, glucose uptake under low glucose conditions (i.e. 5.5mM glucose, 100mg/dL) 
increased the amount of glucose uptake by approximately 20% as compared to glucose 
uptake in myotubes differentiated under high glucose conditions (i.e. 25mM glucose, 
450mg/dL) alone (Figure 11). As such, in order to ensure maximum possible sensitivity 
to insulin stimulation, all subsequent experiments in which glucose uptake was measured 
utilized C2C12 myotube cultures differentiated for 4 days under high glucose conditions 
followed by an additional 2 days of differentiation under low glucose conditions (Figure 
5). 
 Subsequent to assessing the effects of differentiating C2C12 myotubes under high 
and low glucose conditions on insulin stimulated glucose uptake, the optimal 
concentration of insulin required to stimulate maximal glucose uptake in differentiated 
C2C12 myotubes was determined. Using differentiated C2C12 myotube cultures 
differentiated under the low glucose culture conditions described above, an insulin dose-
response curve was constructed using insulin concentrations of 0nM, 2nM, 20nM, 
200nM, 600nM and 1000nM, respectively.  
 
Figure 12. The Effect of Insulin Stimulation on Glucose Uptake in C2C12 Myotubes. An 
initial ANOVA revealed a significant (p < .05) effect of increasing insulin concentration 
on insulin stimulated glucose uptake. Glucose uptake per myotube culture was initially 
expressed as fluorescence units (FU)/(ug) of total protein and then normalized to the 
mean control value which was expressed as a value of one. Normalized values for 
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glucose uptake for each insulin concentration were plotted as the mean +/- standard error. 
(N for each insulin concentration was as follows: 0nM N = 10, 2nM N = 13, 20nM N = 
12, 200nM N = 14, 600nM N = 14, 1000nM N = 14). 
 
 
 
The data presented in Figure 12 suggest that lower concentrations of insulin (i.e. 
0 – 20nM) stimulate myotube glucose uptake, whereas higher concentrations of insulin 
(i.e. 200nM – 1000nM) resulted in what appeared to be active inhibition of glucose 
uptake over and above that seen control cultures (i.e. 0 nM insulin). In order to capture 
the maximum insulin stimulated glucose uptake response in C2C12 myotube cultures, 
while also accounting for the possibility that the concentration of insulin required to 
induce a maximum response may change depending on experimental conditions, all 
subsequent experiments in which the effects of selective cholesterol membrane 
modification on insulin stimulated glucose uptake were studied utilized an insulin dose 
response curve consisting of 0nM 10nM, 25nM, 50nM and 100nM insulin. 
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Using DHP Protein Expression to Spatially Resolve Sarcolemma/T-tubule Membranes in 
Differentiated C2C12 Myotubes  
When C2C12 myotubes were immunohistochemically stained for DHP receptor 
protein followed by confocal microscopy analysis, DHP receptor staining allowed 
identification and spatial resolution of sarcolemma/T-tubule membranes within the 
myotubes (Figure 13). While DHP receptor labelling of sarcolemma/T-tubule 
membranes in C2C12 myotubes is not as robust as observed in adult skeletal muscle in 
vivo [117], the DHP receptor staining pattern observed in Figure 13 clearly discloses 
specific regions of discrete membrane structures within the myotube histologically and 
spatially reminiscent of DHP receptor sarcolemma/T-tubule staining seen in whole 
myofibers in vivo [117]. 
 
Figure 13: Representative Fluorescent Confocal Micrographs of DHP Receptor 
Immunofluorescent Staining In Differentiated C2C12 Myotubes. Panel A illustrates DHP 
receptor protein staining in a single differentiated C2C12 myotube (Scale Bar – 10µm). 
Panel B illustrates a high powered image of the region indicated in Panel A 
demonstrating the spatial arrangement of the sarcolemma/T-tubule membrane system in 
which the DHP receptor resides (Scale Bar – 1µm). 
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Determining Selective Membrane Cholesterol Enrichment Conditions Using a 
Fluorescent Cholesterol Analog  
In order to achieve selective enrichment of internal and external C2C12 myotube 
membranes with cholesterol, the time course of cholesterol trafficking in myotubes 
cultured under specific exogenous cholesterol pulse-chase enrichment culture conditions 
was investigated. The time course of cholesterol trafficking between the tissue culture 
medium and its subsequent localization within specific myotube membrane structures 
was initially determined using a fluorescent analog of cholesterol, 23-
(dipyrrometheneboron difluoride)-24-norcholesterol. While slightly larger than native 
cholesterol, this fluorescent analog when introduced to serum-containing tissue culture 
medium has previously been shown to be taken up and subsequently distributed within 
cell membranes in a similar manner to native cholesterol [145, 146]. Using defined pulse-
chase labeling conditions and the fluorescent cholesterol analog, 23-
(dipyrrometheneboron-difluoride)-24-norcholesterol in culture, followed by 
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morphological confocal microscopy analysis, we demonstrate that specific pulse-labeling 
conditions results in predictable, differential membrane cholesterol enrichment within 
differentiated C2C12 myotubes (Figure 14). In addition, the fluorescent confocal 
microscopy images presented in Figure 14 (Panels A, C, E, G and I) were all acquired 
under identical imaging conditions allowing the relative amount of fluorescent 
cholesterol analog present within myotube membranes to be compared between different 
pulse-chase enrichment conditions. 
 
Figure 14: Representative Fluorescent Confocal Micrographs Illustrating the Spatial 
Localization of the Fluorescent Cholesterol Analog (23-(Dipyrrometheneboron-
Difluoride)-24-Norcholesterol) within Individual C2C12 Myotubes Induced by Specific 
Pulse-Chase Labeling Conditions. Images are single cross sections from within the 
myofiber to demonstrate the enrichment pattern throughout the myofiber following each 
pulse-chase labeling condition. Panels A, C, E, G, I and K are low power images, while 
Panels B, D, F, H, J and L are high power images of the specific regions indicated in 
their matching low power images. Panels A and B illustrate the enrichment of myotube 
membranes with fluorescent cholesterol analog induced by the 4hr Pulse labeling 
condition. Panels C and D illustrate the enrichment of myotube membranes with 
fluorescent cholesterol analog induced by the 4hr Pulse-4hr MβC labeling condition. 
Panels E and F illustrate the enrichment of myotube membranes with fluorescent 
cholesterol analog induced by the 4hr Pulse-16hr Chase labeling condition. Panels G and 
H illustrate the enrichment of myotube membranes with fluorescent cholesterol analog 
induced by the 4hr Pulse-16hr Chase-4hr Pulse labeling condition. Panels I and J 
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illustrate the enrichment of myotube membranes with fluorescent cholesterol analog 
induced by the 4hr Pulse-16hr Chase-4hr MβC labeling condition. Panels A, C, E, G, I 
and K were all acquired under identical imaging conditions allowing relative comparison 
of the amount of fluorescent cholesterol analog present within the membrane to be 
compared. Panels B, D, F, H, I and J were all acquired under identical imaging 
conditions and then processed using image deconvolution software. Dimensions are 
indicated on each image by scale bars.  
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Identifying Which C2C12 Membranes Are Enriched under Different Pulse-Chase 
Labeling Conditions 
In order to determine which membrane structures within C2C12 myotubes were 
enriched with the fluorescent cholesterol analog, confocal microscopy images of C2C12 
myotube membranes labeled under defined pulse-chase labeling conditions were 
compared to similar confocal microscopy images of C2C12 myotubes 
immunohistochemically stained for membrane specific protein markers. The 
sarcolemma/T-tubule DHP receptor staining pattern observed in C2C12 myotubes 
(Figure 13) appears similar to the membrane labelling pattern observed in myotubes 
exposed to a 4hr Pulse label with the fluorescent cholesterol analog (Figure 14, Panels A 
& B), indicating that the 4hr Pulse label condition selectively enriched the 
sarcolemma/T-tubule membranes of C2C12 myotubes. When selective cholesterol 
enrichment conditions were combined with selective cholesterol depletion conditions 
using methyl-β-cyclcodextrin (MβC) to strip cholesterol from the membrane, various 
membrane components appear to be selectively enriched and/or depleted. For example, a 
4h Pulse with the fluorescent cholesterol analog followed by a 4h exposure to MβC 
(Figure 14, Panels C & D) resulted in an overall reduction in the amount of fluorescent 
cholesterol analog remaining in the sarcolemma/T-tubule membrane compared to the 4hr 
Pulse condition alone, with exception of certain regions of the sarcolemma/T-tubule 
membrane which appeared to retain most if not all of the cholesterol accrued during the 
prior 4r Pulse labeling period. However, the fluorescent cholesterol analog labelling 
pattern observed after the 4hr Pulse-16hr Chase labeling (Figure 14, Panels E & F) 
appeared to be spatially different to that of the 4hr pulse labelling pattern, indicating that 
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the 4hr pulse-16hr chase labeling conditions did not selectively enrich the sarcolemma/T-
tubule membranes but rather the internal sarcoplasmic reticulum (SR) membranes of the 
myotube. In addition, the 4h Pulse-16h Chase-4h Pulse labelling condition showed the 
greatest amount of relative cholesterol enrichment of any labeling condition, with 
enrichment of all myotube membranes being observed (Figure 14, Panels G & H). This 
result was in contrast to the 4h Pulse-16h Chase-4h MβC labeling condition (Figure 14, 
Panels I & J) which showed relatively lower levels of enrichment of the internal SR 
membrane compared to that observed in the 4hr Pulse-16hr Chase condition (Figure 14, 
Panels E & F), with exception of certain regions of the SR membrane which appeared to 
retain most if not all of the cholesterol accrued during the prior 4r Pulse-16hr Chase 
labeling period. The results observed from the 4hr Pulse-4hr MBC and 4hr Pulse-16hr 
Chase-4hr MBC labeling conditions may suggest the that the relatively large molecular 
size of the MβC molecule limits its access to all membrane components within the 
myotube resulting in it being unable to remove cholesterol from those physically 
inaccessible regions, or, that certain regions of the membrane are resistance to removal of 
cholesterol using MβC.  
  
Enrichment of C2C12 Myotube Membranes with Native Cholesterol Using with a Water 
Soluble Cholesterol (WSC) Complex 
 Utilizing identical pulse–chase labeling conditions previously determined using 
the fluorescent cholesterol analog, C2C12 myotubes were enriched with native 
cholesterol using a cholesterol/methyl-β-cyclcodextrin (MβC) complex know as water-
soluble cholesterol (WSC).  Since the efficacy of the pulse-chase labeling protocols for 
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native cholesterol membrane enrichment in myotubes could not be monitored using 
confocal microscopy, the total membrane cholesterol content in each myotube culture 
after each defined pulse-chase labeling condition was monitored biochemically to ensure 
that cholesterol enrichment and/or depletion of myotubes with native cholesterol was in 
fact occurring (Figure 15). An initial ANOVA indicated greater total cholesterol content 
in C2C12 myotubes that had been enriched with WSC (p < 0.01). In addition, all 
cholesterol enrichment and/or depletion conditions were significantly (p < 0.01) different, 
with the exception of the 4h Pulse-4h MβC and 4h Pulse-16h Chase-4h MβC conditions 
which were not significantly different from each other (Figure 15). 
 
Figure 15: The Effect of Defined Pulse-Chase Enrichment and Depletion Conditions on 
Total Native Cholesterol Content of C2C12 Myotubes. Total native cholesterol content in 
all cholesterol enrichment and/or depletion conditions was significantly (* = p < 0.01) 
different when compared to the control condition. Further, all conditions were found to 
be different from each other, with the exception of the 4h Pulse-4h MβC (green bar) 
condition and 4h Pulse-16h Chase-4h MβC (orange bar) condition which were not 
significantly different than each other. Individual myotube cultures were batch generated 
from different stock C2C12 myocyte cultures derived from a single parent C2C12 
myocyte culture. The combined data presented below was obtained from a total of 368 
individual myotube cultures generated in six individual 96 well plates. The N for each 
separate condition analyzed is as follows:  Control N = 47, 4h Pulse N = 70, 4h Pulse-4h 
MβC N = 60, 4h Pulse-16h Chase N = 63, 4h Pulse-16h Chase-4h Pulse N = 60, 4h 
Pulse-16h Chase-4h MβC N = 68. Total cholesterol content per myotube culture was 
		
80	
80	
initially expressed as (ng) of total cholesterol/(ug) of total protein and then normalized to 
the mean control value which was expressed as a value of one. Normalized values for 
total cholesterol for each condition were plotted as the mean +/- standard error. 
 
 
In conjunction with the spatial membrane localization information obtained from 
confocal microscopy analysis of C2C12 myotubes labeled with fluorescent cholesterol 
analog, these biochemically derived results demonstrate that using defined sequential 
combinations of exposure to WSC and/or MβC allow the native cholesterol content of 
specific membranes within C2C12 myotubes to be manipulated in a mechanistic and 
predictable fashion.  
 
The Effects of Cholesterol on Basal Glucose Uptake in C2C12 Myotubes 
 While a non-significant (p = 0.086) decrease in non-insulin stimulated basal 
glucose uptake by myotubes was observed following native cholesterol enrichment of the 
sarcolemma/T-tubule membrane using the 4h Pulse labeling condition (Figure 16), an 
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initial One-Way ANOVA did not reveal any significant effects on basal glucose uptake 
associated with any of the various native cholesterol enrichment or depletion conditions. 
 
Figure 16. The Effect of Membrane Cholesterol Enrichment and Depletion on Non-
Insulin Stimulated, Basal Glucose Uptake in C2C12 Myotubes. An initial one-way 
ANOVA revealed no overall effect (p < 0.071) of native cholesterol enrichment and/or 
depletion on basal, non-insulin stimulated glucose uptake. Individual myotube cultures 
were batch generated from different stock C2C12 myocyte cultures derived from a single 
parent C2C12 myocyte culture. The combined data presented below was obtained from a 
total of 238 individual myotube cultures grown in 96 well plates generated on four 
separate occasions. The N for each separate condition analyzed is as follows:  Control N 
= 84, 4h Pulse N = 42, 4h Pulse-4h MβC N = 42, 4h Pulse-16h Chase N = 42, 4h Pulse-
16h Chase-4h Pulse N = 14, 4h Pulse-16h Chase-4h MβC N = 14. Basal glucose uptake 
per myotube culture was expressed initially as fluorescence units (FU)/(ug) of total 
protein and then normalized to the mean control value which was expressed as a value of 
one. Normalized values for basal glucose uptake for each condition were plotted as the 
mean +/- standard error. 
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These data suggest that constitutive myotube basal glucose uptake mediated via 
GLUT1 transporters located in the sarcolemma/T-tubule membranes of myotubes 
remains unaffected by short-term enrichment or depletion of myotube membranes with 
cholesterol. However, the non-significant decrease observed in basal glucose uptake 
observed after sarcolemma/T-tubule cholesterol enrichment (i.e. 4hr Pulse) is intriguing. 
These preliminary data indicate that while basal, GLUT1 mediated glucose uptake is not 
directly impacted by the short-term changes in membrane cholesterol content described 
in this study, it is possible that basal non-insulin stimulated, GLUT1-mediated glucose 
uptake pathways may be altered under chronic hypercholesteremic conditions. 
 
The Effects of Cholesterol Enrichment and/or Depletion Conditions on Insulin-Stimulated 
Glucose Uptake in C2C12 Myotubes 
 The effects on insulin stimulated glucose uptake of five separate 
enrichment/depletion conditions were compared to control conditions using a 5X6 
		
83	
83	
ANOVA (Table 1). This analysis indicated that the Control, the 4hr Pulse and the 4hr 
Pulse-4hr MBC conditions were all significantly different from each other at all insulin 
concentrations tested (Figure 17, Table 1). Importantly, the significant inhibition of 
insulin stimulated glucose uptake observed after enrichment of the sarcolemma/T-tubule 
membrane with cholesterol using the 4hr Pulse condition was partially rescued in 4hr 
Pulse-4hr MBC condition when cholesterol was subsequently removed by stripping with 
MBC (Figure 17). 
 
 
Figure 17.  The Effect of Membrane Cholesterol Enrichment and/or Depletion on Insulin 
Stimulated Glucose Uptake in C2C12 Myotubes. Results of a 5X6-way ANOVA analysis 
(Table 1) indicated that insulin stimulated glucose uptake in the Control, the 4hr Pulse 
labeling condition, and the 4hr Pulse-4hr MBC labeling condition, labeling conditions 
were all significantly (p < 0.01) different from each other at all insulin concentrations 
tested. In addition, while the 4hr Pulse-16hr Chase labeling condition was not 
significantly different overall from the control condition, the concentration of insulin 
required to induce the maximal insulin stimulated glucose uptake response was 
significantly (p < 0.01) increased from 10nM to 50nM insulin. Individual myotube 
cultures were batch generated from different stock C2C12 myocyte cultures derived from 
a single parent C2C12 myocyte culture. The combined data presented below was 
obtained from a total of 882 individual myotube cultures grown in 96-well plates 
generated on 3 separate occasions. The N for each separate condition analyzed is as 
follows:  Control N = 252 (0nM N = 84, for all other insulin concentrations N = 42) 4h 
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Pulse N = 210 (42 data points per insulin concentration), 4h Pulse-4h MβC N = 210 (42 
data points per insulin concentration), 4h Pulse-16h Chase N = 210 (42 data points per 
insulin concentration). Glucose uptake per myotube culture was initially expressed as 
fluorescence units (FU)/(ug) of total protein and then normalized to the mean control 
value which was expressed as a value of one. Normalized values for glucose uptake for 
each condition and insulin concentration were plotted as the mean +/- standard error. 
 
These data provide direct experimental evidence that increased membrane 
cholesterol content is causally related to the disruption of insulin stimulated glucose 
uptake in a highly differentiated in vitro model of skeletal myofibers. In addition, while 
overall insulin stimulated glucose uptake in the 4hr Pulse-16hr Chase enrichment 
condition was not significantly different from control levels, maximal glucose uptake 
occurred at approximately five times the insulin concentration required under control 
conditions (i.e. 50nM insulin as compared to 10nM insulin) (Figure 17, Table 1). These 
data provide direct experimental evidence that selective cholesterol enrichment of 
myotube sarcoplasmic reticulum (SR) membranes induces insulin insensitivity similar to 
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that seen in skeletal myofibers of individuals suffering from a range of pathological 
conditions, such as obesity, hypercholesterolemia and Type 2 diabetes. 
The effects of selectively enriching both the sarcolemma/T-tubule and SR 
membranes with cholesterol (4hr Pulse-16hr Chase-4hr Pulse), or, selectively enriching 
the SR membrane while subsequently depleting the sarcolemma/T-tubule membrane (4hr 
Pulse-16hr Chase-4hr MβC) on insulin stimulated glucose uptake were also compared to 
that observed under control conditions (Figure 18). 
 
Figure 18. The Effect of Sequential Cholesterol Enrichment and Depletion on Insulin 
Stimulated Glucose Uptake in C2C12 Myotubes. Results of a 5X6-way ANOVA analysis 
(Table 1) indicated that insulin stimulated glucose uptake induced by both the 4hr Pulse-
16hr Chase-4hr Pulse labeling condition and the 4hr Pulse-16hr Chase-4hr MβC labeling 
condition were significantly different than that observed in the control condition (p < 
0.01). Individual myotube cultures were batch generated from different stock C2C12 
myocyte cultures derived from a single parent C2C12 myocyte culture. The combined 
data presented below was obtained from a total of 321 individual myotube cultures 
generated in 96 well plates on three separate occasions. The N for each separate condition 
analyzed is as follows: Control N = 252, 4hr Pulse-16hr Chase-4hr Pulse N = 69 (14 data 
points for all insulin concentrations except at 50nM insulin, with 13 data points) and 4hr 
Pulse-16hr Chase-4hr MβC N = 69 (14 data points for each insulin concentration except 
for 0nM insulin with 13 data points). Glucose uptake per myotube culture was initially 
expressed as fluorescence units (FU)/(ug) of total protein and then normalized to the 
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mean control value which was expressed as a value of one. Normalized values for 
glucose uptake for each condition were plotted as the mean +/- standard error. 
 
 
 
Both the 4hr Pulse-16hr Chase-4hr MβC and the 4hr Pulse-16hr Chase-4hr Pulse 
labeling conditions were significantly (p < 0.01) different from the control (Figure 13, 
Table 1), however not different from each other. Further, the 4hr Pulse-16hr Chase-4hr 
MβC labeling condition was different from the control condition at every insulin 
concentration tested (p < 0.05), whereas the 4hr Pulse-16hr Chase-4hr Pulse labeling 
condition was not different from the 4hr Pulse-16hr Chase-4hr MβC labeling condition at 
all insulin concentrations tested.  
 
Table 1 Results from a 5X6 ANOVA Analysis on the Effects of Different Membrane 
Cholesterol Enrichment and/or Depletion Conditions on Insulin Stimulated Glucose 
Uptake. A 5x6-way ANOVA revealed that insulin stimulated glucose uptake in the 4h 
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Pulse, 4h Pulse-4h MβC, 4h Pulse-16h Chase-4hr Pulse and 4hr Pulse-16hr Chase-4hr 
MβC labeling conditions were all different from control conditions (p < 0.01). One-way 
ANOVAs within each enrichment conditions revealed significantly increased insulin 
stimulated glucose uptake responses overall in the control (p < 0.01), 4hr Pulse (p < 
0.01), 4hr Pulse-16h Chase (p < 0.01), and 4hr Pulse-4hr MβC conditions (p < 0.05). 
Significance differences in glucose uptake between cholesterol enrichment/depletion 
conditions, within individual conditions across multiple insulin concentrations, or 
between conditions at the same insulin concentration are indicated in Table 1. (* = 
different from control at p < 0.05, # = different from 0nM at p < 0.05, † = different from 
control at respective insulin concentration at p < 0.05).  
 	 Membranes	
Enriched	
Insulin	Concentration	
Enrichment	
Condition	 SL	 SR	 0nM	 10nM	 25nM	 50nM	 100nM	
Control	 NA	 NA	 1	±.086	N=84	 1.35#	±.086	N=42	 1.31#	±.046	N=42	 1.28#	±.038	N=42	 1.14	±.037	N=42	
4h	Pulse*	 +	 No	Change	 1	±.055	N=42	 0.95†	±.074	N=42	 0.9†	±.065	N=42	 0.84†	±.043	N=42	 0.72#†	±.028	N=42	
4h	Pulse	4h	
MβC*	 +/-	
No	Change	 1	±.026	N=42	 1.11	±.031	N=42	 1.13#	±.033	N=42	 1.06†	±.03	N=42	 0.85#†	±.034	N=42	
4h	Pulse	
16h	Chase	
No	Change	 +	 1	±.051	N=42	 1.15	±.06	N=42	 1.28#	±.086	N=42	 1.43#	±.081	N=42	 1.12	±.048	N=42	
4h	Pulse	
16h	Chase	
4h	Pulse*	
+	 +	 1	±.041	N=13	 1.08	±.039	N=14	 1.07	±.05	N=14	 1.09	±.043	N=14	 1.06	±.068	N=14	
4h	Pulse	
16h	Chase	
4h	MβC*	
-	 +	 1	±.029	N=14	 1.02@	±.053	N=14	 0.87†	±.033	N=13	 0.97†	±.032	N=14	 0.9†	±.042	N=14	
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Chapter 5 – Discussion 
Previous studies have demonstrated that there is a relationship between various 
environmental conditions, such as a high fat diet, physical inactivity and aging, and the 
development of a range of chronic pathological conditions such as obesity, 
hypercholesterolemia, metabolic syndrome, aged-related sarcopenia and Type 2 diabetes. 
Two common characteristics associated with these chronic pathological conditions are 
evidence of lipid metabolism dysregulation and a range of structural and metabolic 
adaptations observed in skeletal muscle prior to the onset or during the course of these 
diseases. 
The overall purpose of this study was to investigate the potential causal 
relationship(s) between muscle membrane cholesterol content (previously shown to be 
impacted by a high fat diet, obesity, hypercholesterolemia and physical inactivity) and 
disrupted insulin receptor signaling and insulin stimulated glucose uptake in skeletal 
myofibers. In order to investigate this relationship, we first developed and characterized a 
well-defined in vitro tissue culture model consisting of highly differentiated C2C12 
myotubes that exhibit both the morphological and biochemical markers of skeletal 
myofibers in vivo (Figures 7, 8 and 9). Access to this controlled and highly reproducible 
in vitro model, coupled with the development of novel approaches for selectively 
manipulating cholesterol content of specific myotube membranes in vitro, has allowed 
the mechanistic investigation of how increased membrane cholesterol content and its 
cellular location might be responsible for disrupted insulin signaling and insulin 
stimulated glucose uptake observed in skeletal myofibers in vivo.  
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Previous research has suggested that alterations in myofiber membrane 
cholesterol content are correlated with the onset and development of insulin insentivitiy 
and glucose tolerance in vivo [1]. In addition, a number of previous tissue culture studies 
have provided data supporting the concept that changing total membrane cholesterol 
content in cultured adipocytes modulates insulin signaling and insulin mediated glucose 
uptake in these cells [13, 18]. Building on these previous observations, the data presented 
in our current study provides direct experimental evidence that increased membrane 
cholesterol content, as well as the specific membrane component in which it is increased, 
is causally linked to disruptions in insulin signaling and insulin stimulated glucose uptake 
by skeletal muscle-derived myotubes in culture. As such, our results provide a 
mechanistic explanation of how increases in cholesterol membrane content can disrupt 
the underlying cellular mechanisms involved in insulin receptor signaling, insulin 
stimulated glucose uptake and GLUT4 translocation in skeletal muscle. These data also 
provide a mechanistic model capable of explaining the underlying relationship between 
conditions exhibiting abnormal regulation of lipid metabolism and increased circulating 
cholesterol levels, such as obesity and hypercholesterolemia, and the onset of insulin 
insensitivity and glucose tolerance in conditions such as metabolic syndrome and Type 2 
diabetes. 
 
Development of a Well-Defined, Highly Differentiated C2C12 Myotube Model 
The present study set out to a develop a highly controlled and reproducible in 
vitro model of skeletal myofibers consisting of highly differentiated C2C12 myotubes 
exhibiting the morphological and biochemical markers of terminally differentiated 
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skeletal myofibers in vivo. This model was then used to investigate the effects of 
selective enrichment or depletion of membrane cholesterol upon insulin signaling and 
insulin stimulated glucose uptake. While C2C12 myotube cultures are a well-recognized 
in vitro model in which to study physiologically relevant events that occur in skeletal 
myofibers in vivo [12, 39, 43, 44, 47, 49, 50, 139], it is not always clear from the 
literature how these myotube cultures were generated experimentally, whether or not 
these myotubes exhibited the morphological and biochemical markers associated with 
terminal differentiation of skeletal myofibers in vivo, or, if myotube cultures generated 
over time remained consistent in their response to experimental stimuli.  
The C2C12 myotube model reported here addressed many of these issues by 
controlling for tissue culture conditions and growth parameters already known to 
introduce variability into tissue culture models including: creating stock C2C12 myocyte 
cultures with a known passage number from which all subsequent myotube cultures were 
generated; utilizing media preparations that mimic physiologically relevant conditions in 
vivo; utilizing defined myocyte seeding densities and culture periods to ensure uniform 
myocyte growth and myotube differentiation in culture over time; and confirming 
myotube differentiation by both morphological criteria and biochemical expression of 
skeletal muscle terminal differentiation markers. In addition, to ensure maximum 
response to insulin stimulation, C2C12 myotube cultures were cultured and differentiated 
in tissue culture medium containing defined amounts of glucose mimicking physiological 
glucose concentrations in vivo. By defining and controlling such tissue culture 
parameters, we have developed a highly reproducible C2C12 myotube tissue culture 
model of skeletal myofibers in vivo that exhibit a high degree of terminal differentiation 
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as demonstrated by the temporally predictable generation of large, three dimensional, 
multi-nucleated fusiform myotubes that express both myosin heavy chain (MHC) and 
dihydropyridine (DHP) receptor (Figure 8 and 9), as well as a spatially organized, intra-
myofiber T-tubule membrane system (Figure 13). 
Further, the use of 2-NBDG, a fluorescent analog of glucose, allowed fluorescent 
microscopy visualization of both basal and insulin stimulated glucose uptake at the 
individual cellular level.  Direct microscopic analysis provided visual evidence that 
glucose uptake in these cultures was associated overwhelming with glucose uptake by 
myotubes rather than by any undifferentiated myocytes remaining in the culture (Figure 
10). In addition, confirmation that the vast majority of the 2-NBDG was accounted for by 
myotube uptake allowed this in vitro model to be configured into a 96-well plate format, 
high-throughput assay designed to study the effects of membrane cholesterol on insulin 
signaling and insulin stimulated glucose uptake. 
 
High Glucose and Insulin-Induced Insulin Resistance in Cultured Cells 
 Some authors have found little to no insulin-stimulated glucose uptake response 
in C2C12 myotube cultures [12, 38, 44, 50], while others demonstrate clear experimental 
responses to insulin [43]. Adding to this ambiguity, some researchers have shown that 
tissue culture under high glucose conditions induces insulin resistance and that exposure 
of these cells to low glucose conditions prior to insulin stimulation rescues the insulin 
response [31, 43]. For example, Nedechi et al reported a 19% increase in insulin-
stimulated glucose uptake in C2C12 myotubes cultured in high glucose conditions as 
compared to a 42% increase in insulin-stimulated glucose uptake in myotubes grown in 
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high glucose and then exposed to low glucose media. Further, it was reported that high 
glucose media inhibited the insulin response after only 5 minutes of exposure [43].  
 Leontieva et al found similar results demonstrating high glucose-induced insulin 
resistance using RPE cells [31]. To gain insight into the mechanism by which this occurs, 
these researchers used rapamycin to inhibit mTOR activation in the presence of high 
glucose-induced insulin resistance resulting in the restoration of insulin stimulated 
glucose uptake in the presence of high glucose. Leontieva et al also used an SK6 inhibitor 
to gain further insight into the cellular mechanisms responsible for high glucose-induced 
insulin resistance. SK6, a serine/threonine kinase, is an inhibitor of insulin receptor 
autophosphorylation, while itself inhibited by mTOR. Leontieva et al found that SK6 
inhibitors restored insulin sensitivity in the presence of high glucose-induced mTOR over 
activation, demonstrating the mechanism of a negative feedback loop that induces insulin 
resistance (displayed in Figure 3) [31].  
This negative feedback loop was further explored using insulin to induce insulin 
resistance. Leontieva et al found that over stimulation with insulin using 1ug/mL 
(175nM) overnight inhibited any further stimulation as measured by Akt activation in 
RPE cells [31]. Although this effect was observed in RPE cells and not differentiated 
skeletal muscle myotubes, Leontieva et al demonstrated many common characteristics 
between RPE cells and C2C12 myotubes in regards to insulin stimulation and glucose 
metabolism, and therefore it could be argued the same negative feedback mechanisms 
may exist in C2C12 myotubes in vitro and by extension skeletal muscle myofibers in 
vivo. 
		
93	
93	
While we did not detect any significant effect of culture in low glucose conditions 
on insulin stimulated glucose uptake (Figure 11), we did however observe a small 
increase (approximately 20%) in the sensitivity of differentiated C2C12 myotubes to 
insulin. Based on the possibility that C2C12 myotubes may develop high glucose-induced 
insulin insentivitiy, C2C12 myotube cultures utilized in this study were maintained in 
low glucose medium during the final two days of differentiation in order to ensure 
maximal sensitivity to subsequent insulin stimulation.   
 
Glucose Uptake in Response to Various Insulin Concentrations 
Review of the literature describing the use of C2C12 myotube cultures as a model 
in which to study insulin receptor signaling and insulin stimulated glucose uptake 
provides contradictory information on both the degree of C2C12 myotube sensitivity to 
insulin and the optimal amount of insulin required to induce maximal insulin stimulated 
glucose uptake. While it is possible that some of this ambiguity may have arisen because 
the myotubes utilized in previous studies were generated under different culture 
conditions or exhibited varied stages of differentiation, it is also possible that other 
cellular related mechanisms may be responsible. 
In the current study, preliminary pilot experiments were carried out to investigate 
the appropriate concentration of insulin to induce maximal insulin stimulated glucose 
uptake in differentiated C2C12 myotubes. Initially, concentrations of 2nM, 20nM, 
200nM, 600nM and 1000nM of insulin were used to induce insulin stimulated glucose 
uptake in differentiated C2C12 myotube cultures (Figure 12). This broad dose-response 
range was utilized to capture the most commonly used insulin concentration (i.e. 100nM) 
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previously reported in the literature to induce insulin stimulated glucose uptake in C2C12 
myotubes. In C2C12 myotubes cultured under controlled differentiation conditions, the 
maximal insulin-stimulated glucose uptake response (approximately 35% above basal 
glucose uptake levels) was observed somewhere below 20nM insulin, whereas insulin 
concentrations above 200nM resulted in inhibition of glucose uptake (Figure 12). Based 
on these initial results, all subsequent experiments investigating the effects of membrane 
cholesterol manipulation on insulin stimulated glucose uptake (Figures 17 and 18) 
utilized a range of insulin concentrations spanning the region of the insulin dose-response 
curve corresponding to the predicted maximal insulin stimulated glucose uptake response 
(i.e. 0nM, 10nM, 25nM, 50nM and 100nM insulin). 
While there are many examples in the research literature of repeated agonist-
mediated receptor activation leading to receptor inactivation or down-regulation of 
receptor protein expression, including the development of insulin insensitivity in 
hyperinsulinemic patients [148], the majority of such negative feedback loops on cell 
signaling events occur after prolonged, chronic elevations in agonist concentration. 
However, the inhibition of insulin stimulated glucose uptake in C2C12 myotubes 
observed with insulin concentrations above 100nM (Figures 12, 17 and 18) occurred 
within 30 minutes of exposure to insulin, rather than after a prolonged period of time.  
Our experimental observations indicate that increased insulin concentrations (i.e. 
above 100nM insulin) rapidly induce inhibition of insulin stimulated glucose uptake in 
control C2C12 myotubes. Based on the time course of this inhibitory effect, these data 
suggest that the acute inhibition (i.e. within 30 min) in insulin stimulated glucose uptake 
is mediated by either inactivation of existing insulin receptors located in the external 
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sarcolemma/T-tubule membranes of the myotube, or, inhibition of subsequent 
intracellular elements of the insulin signaling pathway, while the rapid onset (i.e. 30 
minutes) of this effect makes it highly unlikely that inhibition is due to receptor protein 
downregulation. 
While the exact cellular mechanism(s) responsible for the acute inhibitory effect 
of large insulin concentrations on insulin stimulated glucose uptake in C2C12 myotubes 
remain unknown, one possible explanation comes from previous studies which 
demonstrated that over-activation of the insulin receptor rapidly induced a negative 
feedback loop on insulin receptor signaling through inhibition of the Akt-mTOR portion 
of the signaling pathway. Although these observations were made in cultured RPE cells, 
since the insulin receptor mediated Akt-mTOR signaling pathway is highly conserved 
across multiple cells types, our experimental data supports the contention that a similar 
negative feedback loop may operate in both C2C12 myotubes and skeletal muscle in vivo. 
Interestingly, previous studies utilizing C2C12 myotubes in which to study insulin 
receptor signaling and insulin stimulated glucose uptake mechanisms routinely employ 
only a single insulin stimulation concentration of 100nM insulin with stimulation periods 
ranging from 20min to 16hr [12, 38, 43, 44, 50]. Using these experimental conditions, a 
number of studies have reported little or no response to insulin stimulation [12, 44, 50, 
139]. While it is possible that the C2C12 myotubes utilized in these previous studies may 
not have been fully differentiated (e.g. leading to under-developed insulin receptor 
signaling pathways), our experimental data suggests that it may be more appropriate to 
employ a range of lower insulin concentrations in order to capture the maximal insulin 
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stimulated glucose uptake response and to prevention potential insulin receptor 
inactivation. 
 
Pulse-Chase Labeling of Myotube Membranes Using a Fluorescent Cholesterol Analog  
 Pulse-chase labeling protocols designed to enrich specific C2C12 myotube 
membrane components were experimentally defined utilizing a fluorescent cholesterol 
analog introduced to the tissue culture medium. This approach allowed subsequent 
visualization and spatial resolution of the intracellular location of the fluorescent 
cholesterol analog within the membranes of differentiated C2C12 myotubes using 
confocal microscopy. Analysis of confocal images collected from each defined pulse-
chase labeling condition demonstrated differential cholesterol enrichment and/or 
depletion of specific membranes within the myotube (Figure 14). By comparing confocal 
images of C2C12 myotubes immunostained for the DHP receptor, a specific spatial 
marker of sarcolemma/T-tubule membranes (Figure 13), the membrane location of the 
fluorescent cholesterol analog induced by each defined pulse-chase labeling condition 
could be deduced. 
The spatial organization of the sarcolemma/T-tubule myotube membrane 
disclosed using DHP receptor immunostaining (Figure 13) visually resembles a “mesh-
like” staining pattern with examples of “circular” membrane components. A similar, but 
much more morphologically distinct, circular “mesh-like” staining pattern organized 
around individual myofibrils has been previously described for the DHP receptor staining 
pattern in the sarcolemma/T-tubule system of skeletal myofibers in vivo [117]. 
Interestingly, the circular membrane components observed in C2C12 myotubes could 
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easily be imagined to be wrapped around the nascent myofibrils observed within 
differentiated C2C12 myotubes stained for MHC protein (Figure 8). A similar spatially 
organized, circular “mesh-like” fluorescent cholesterol analog labeling pattern was also 
observed in in confocal images of differentiated myotubes collected from the 4hr Pulse 
labeling condition (Figure 14, Panels A and B). Considering the requirement for the 
fluorescent cholesterol analog to first be incorporated into the external sarcolemma 
membrane of the myotube, the relatively short exposure time to the fluorescent 
cholesterol analog (i.e. 4hr), and the spatial similarities between the DHP receptor 
staining (Figure 13) and the fluorescent cholesterol analog membrane labeling patterns 
observed (Figure 14, Panels A and B), our results are highly consistent with the 
conclusion that the 4hr Pulse labeling condition results in selective cholesterol 
enrichment of the sarcolemma/T-tubule membranes of differentiated C2C12 myotubes. 
This conclusion was further supported by the fluorescent cholesterol analog membrane 
labeling pattern observed in the 4h Pulse-4h MβC labeling condition (Figure 14, Panels 
C and D) which clearly demonstrates the removal of the fluorescent cholesterol analog 
from the membranes in which it was initially deposited by a prior 4hr Pulse. Since there 
is no experimental evidence that MβC is either incorporated into cell membranes or 
actively transported into cells during 4hr of exposure, these data suggest that for MβC to 
have removed the fluorescent cholesterol analog previously deposited by the 4hr Pulse, 
MβC could only have removed fluorescent cholesterol analog from membranes in direct 
contact with the external tissue culture medium (i.e. the sarcolemma/T-tubule 
membrane).  
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When the fluorescent cholesterol analog membrane labeling induced by the 4hr 
Pulse-16hr Chase labeling condition (Figure 14, Panels E and F) was analyzed, subtle 
differences in the spatial labeling pattern were observed compared to the sarcolemma/T-
tubule labeling observed in the 4hr Pulse labeling condition (Figure 14, Panels A and 
B), including a lack of complete circular “mesh-like” membrane labeling. These 
differences suggested that internal sarcoplasmic reticulum (SR) membranes rather than 
sarcolemma/T-tubule membranes had been selectively enriched in the 4hr Pulse-16hr 
Chase labeling condition. However, in the absence of comparative images of 
sarcoplasmic reticulum (SR) membranes identified using a protein marker similar to 
sarcolemma/T-tubule membrane DHP receptor staining, definitive identification of the 
SR membrane component in this study was impossible. However, since the high power 
confocal images of C2C12 myotubes labeled with fluorescent cholesterol analog (Figure 
14, Panels A, C, E, G and I) were all collected under identical imaging conditions, 
evidence to support our conclusion that the 4hr Pulse-16hr Chase labeling condition 
selectively enriched the SR membrane with cholesterol, rather than the sarcolemma/T-
tubule membrane, comes from visually comparison of the overall fluorescent labeling 
intensity observed in the 4hr Pulse labeling condition. The fluorescent intensity 
associated with sarcolemma/T-tubule membrane labeling observed in the 4hr Pulse 
labeling condition is greater than observed in the 4hr Pulse-16hr Chase labeling 
condition. These results indicate that either the fluorescent cholesterol analog initially 
deposited into the sarcolemma/T-tubule membranes during the 4hr Pulse had been 
redistributed into additional membrane components during the subsequent 16hr Chase 
(thereby reducing the fluorescent signal per unit volume of membrane in the image), or, 
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alternatively the fluorescent cholesterol analog may have been metabolized within the 
myotube during the 16hr Chase. Since the fluorescent cholesterol analog utilized in this 
study has been used to track cell lineage in Zebrafish from the embryo stage through the 
adult stage [149], it seems unlikely that the reduction in fluorescent signal observed in the 
4hr Pulse-16hr Chase labeling condition as compared to the 4hr Pulse labeling condition 
would be as a result of the label being metabolized during the 16hr Chase period. As 
such, the most logical explanation for the reduction in fluorescent signal observed in the 
4hr Pulse-16hr Chase is that the label had been distributed into additional membrane 
components within the myotube (i.e. SR membrane). 
In contrast, the 4hr Pulse-16 Chase-4h Pulse labeling condition (Figure 14, 
Panels G and H) resulted in much greater labeling of both sarcolemma/T-tubule and SR 
membrane components in the C2C12 myotubes compared to all other labeling conditions 
(Figure 14, Panels A, C, E, G and I). These results provide additional supporting 
evidence that the 4hr Pulse-16hr Chase labeling condition selectively enriched the SR 
membrane rather than the sarcolemma/T-tubule membrane, as it would be predicted that 
the use of two sequential exposures to the fluorescent cholesterol analog separated by a 
16hr Chase period would firstly enrich the SR membrane and then for a second time 
enrich the sarcolemma/T-tubule membrane. In addition, the membrane labeling pattern 
observed in the 4hr Pulse-16 Chase-4h Pulse (Figure 14, Panels G and H) appears to 
resemble a combination of both membrane labeling patterns seen in the 4hr Pulse (Figure 
14, Panels A and B) and 4hr Pulse-16hr Chase (Figure 14, Panels E and F) labeling 
conditions, including the complete circular “mesh-like” membrane labeling seen only in 
the 4hr Pulse labeling condition. 
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Similarly, if the overall model of how cholesterol is enriched, depleted and 
trafficked within myotube membranes using the pulse-chase labeling techniques 
developed in this study is correct, then the 4hr Pulse-16hr Chase-4hr MBC labeling 
condition (Figure 14, Panels I and J) would be predicted not only to result in SR 
membrane enrichment but also the removal of any fluorescent cholesterol analog 
remaining in the sarcolemma/T-tubule from the initial 4hr Pulse. Confocal images 
collected from C2C12 myotubes labeled with the fluorescent cholesterol analog using the 
4hr Pulse-16hr Chase-4hr MBC labeling condition confirmed that prediction. 
Confocal analysis of C2C12 myotubes labeled with fluorescent cholesterol analog 
and then depleted using MβC revealed the existence of certain membrane regions within 
the myotubes which appear resistance to cholesterol depletion using MβC (Figure 14, 
Panels C, D, I and J). The molecular weight of MβC is approximately 23 times larger 
than either native cholesterol or the fluorescent cholesterol analog. Because the T-tubule 
membranes are contiguous invaginations of the sarcolemma membrane extending into the 
central region of the myotube, MβC may not have had physical access to the entire 
sarcolemma/T-tubule membrane surface leading to certain regions of the sarcolemma/T-
tubule membrane that still contain regions that appear to be enriched with fluorescent 
cholesterol analog. A second possibility is that these remaining enriched membrane 
regions represent clusters of lipid rafts or caveolae in the sarcolemma/T-tubule membrane 
that are resistant to extraction of cholesterol via MβC, or, alternatively endocytic vesicles 
derived from labeled sarcolemma/T-tubule membrane components that have been 
internalized into the C2C12 myotube.  
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Pulse-Chase Labeling using Native Cholesterol Followed by Total Cholesterol 
Measurements  
While the spatial localization of native cholesterol delivered to C2C12 myotubes 
using Water Soluble Cholesterol (WSC) cannot be visually confirmed using confocal 
microscopy, analysis of the total cholesterol content in C2C12 myotubes confirm that the 
overall amount of native cholesterol delivered to the myotubes using identical pulse-
chase labeling (Figure 15) parallels that observed in the case of the fluorescent 
cholesterol analog (Figure 14). For example, 4hr Pulse labeling with WSC resulted in 
approximately a 2.5-fold increase in total myotube native cholesterol content, while 4hr 
Pulse-4h MβC labelling resulted in a 42% increase in total myotube native cholesterol 
content (Figure 15). These quantitative results are consistent with the relative amount of 
fluorescent cholesterol analog enrichment directly observed confocal microscopy under 
these labeling conditions using (Figure 14, Panels A and C). Similarly, 4hr Pulse-16hr 
Chase-4hr Pulse labeling with WSC resulted in approximately a 4-fold increase in total 
myotube native cholesterol content, a result consistent with the relative amount of 
fluorescent cholesterol analog enrichment directly observed using confocal microscopy in 
this labeling condition (Figure 14, Panel G). 
In addition, whereas 4hr Pulse labeling with WSC resulted in a 2.5 fold increase 
in total membrane cholesterol, the 4hr Pulse-16hr Chase labeling with WSC resulted in 
approximately a 1.75-fold increase in total myotube native cholesterol content (Figure 
15) suggesting that a portion of the native cholesterol delivered to the sarcolemma/T-
tubule system in the initial 4hr Pulse may have been metabolized by the myotubes. 
Alternatively, the difference observed between these two conditions may be as a result of 
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small amounts of residual MβC (derived from the WSC complex original present in the 
initial 4hr Pulse reagent) removing native cholesterol from the sarcolemma/T-tubule 
membrane. 
Taken together, the spatial membrane localization information obtained from 
confocal microscopy analysis of myotubes labeled with fluorescent cholesterol analog 
coupled with the results of total membrane cholesterol analysis after WSC labeling, 
demonstrate that using defined sequential combinations of exposure to WSC and/or MβC 
allow the cholesterol content of specific membranes within myotubes to be manipulated 
in a mechanistic and predictable fashion. These qualitative and quantitative results 
concerning myotube membrane cholesterol content and intracellular location after 
defined pulse-chase labeling provide further evidence and support for the overall model 
suggested in this study for how cholesterol is trafficked within myotube membranes.   
 
Cholesterol Enrichment on Basal Glucose Uptake 
 An initial one-way ANOVA examining basal glucose uptake across all 
enrichment conditions showed no overall effect, nor any differences between control 
conditions and any experimental conditions (Figure 16). Given that selective membrane 
cholesterol enrichment has such significant effects on insulin-stimulated glucose uptake 
in C2C12 myotubes (Figures 17 and 18, Table 1), these experimental data suggest that 
translocation of the different glucose transporters GLUT1 and GLUT4 responsible for 
basal and insulin stimulated glucose uptake respectively, is differentially regulated within 
the C2C12 myotube.  
 
		
103	
103	
Cholesterol Enrichment and Insulin Resistance in C2C12 Myotubes 
 The data presented here demonstrate that membrane cholesterol enrichment 
inhibits insulin stimulated glucose uptake across multiple insulin concentrations. This is 
most evident in the 4hr Pulse enrichment condition which inhibited insulin stimulated 
glucose uptake at every insulin concentration tested (Figure 17 and Table 1) and 
resulted in a 2.5-fold increase in total native cholesterol content (Figure 15). These data 
support the overall hypothesis that increased cholesterol content of C2C12 myotube 
membranes inhibits insulin stimulated glucose uptake. In the case of the 4h Pulse-4h 
MβC enrichment condition, cholesterol was first delivered to the sarcolemma/T-tubule 
membrane and then removed using MβC. This sequence of events was demonstrated by 
both fluorescent cholesterol analog labeling (Figure 14, Panels A and C), and by 
comparison of the total cholesterol content in C2C12 myotubes enriched with native 
cholesterol using the 4hr Pulse condition compared to 4hr Pulse-4hr MβC condition 
(Figure 15). The removal of cholesterol from the sarcolemma/T-tubule membrane 
following initial enrichment in the 4hr Pulse-4hr MβC condition partially rescued the 
complete inhibition of the insulin-stimulated glucose uptake response observed in the 4hr 
Pulse condition (Figure 17 and Table 1). The data from this “rescue” experiment 
demonstrates that increased cholesterol within the sarcolemma/T-tubule membrane is 
causally related to the inhibition of insulin-stimulated glucose uptake by C2C12 
myotubes observed in the 4h Pulse condition.  
However, unlike the 4hr Pulse condition that resulted in selective enrichment of 
sarcolemma/T-tubule membranes, the 4hr Pulse-16hr Chase condition resulted in 
selective enrichment of sarcoplasmic reticulum membranes (Figure 14, Panels E and F). 
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Insulin stimulated glucose uptake in this enrichment condition was not found to be 
significantly different overall from control conditions (Table 1). However, the maximal 
insulin stimulated glucose uptake response in this enrichment condition was not at 10nM 
insulin as in control conditions, but rather at 50nM insulin. This rightward-shift of the 
insulin dose-response curve suggests that cholesterol enrichment of the sarcoplasmic 
reticulum membrane induces insulin resistance in C2C12 myotubes.  
 Increased membrane cholesterol in external plasma membranes has been 
demonstrated to inhibit SNARE-mediated fusion of intracellular vesicle membranes to 
the plasma membrane due to steric hindrance of SNARE proteins by cholesterol. 
Specifically, increased membrane cholesterol in sarcolemma/T-tubule membranes has 
been shown to alter the physical orientation of SNARE proteins located in caveolae, 
resulting in reduced docking of intracellular vesicles during fusion [129]. Such 
cholesterol-induced disruption of SNARE-mediated vesicle fusion may explain the 
inhibition of insulin stimulated glucose uptake observed after sarcolemma/T-tubule 
cholesterol enrichment reported in the present study. Since insulin stimulated glucose 
uptake in skeletal muscle is dependent on the translocation of GSV membranes 
containing GLUT4 to, and subsequent fusion with the sarcolemma/T-tubule membrane 
via SNARE-mediated proteins, cholesterol enrichment of the sarcolemma/T-tubule 
membrane as observed after a 4hr Pulse label would be predicted to result in reduced 
fusion of GLUT4-containing GSV and a decrease in insulin stimulated glucose uptake. It 
is also possible that other membrane-bound proteins involved in insulin signaling 
pathway, including the insulin receptor itself, are also sterically hindered by increased 
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sarcolemma/T-tubule cholesterol membrane content, although we are not aware of any 
experimental evidence in the literature to support this contention.  
 Another way cholesterol enrichment of muscle membranes may result in 
inhibition of insulin-stimulated glucose uptake also involves GSV fusion, but through a 
different mechanism than cholesterol-mediated steric hindrance of SNARE proteins 
located in the sarcolemma/T-tubule membrane. The basis of this potentially novel 
inhibitory mechanism derives from fundamental observations concerning the fusogenic 
capacity of lipid membrane vesicles which contain different amounts of cholesterol. 
Using isolated membrane vesicle preparations prepared with various combinations of 
phospholipids and cholesterol in the vesicle membrane, it has been demonstrated that 
phospholipid membrane vesicles with differing cholesterol membrane content fuse less 
efficiently or not at all compared to membranes that contain either no cholesterol or 
similar amounts of cholesterol [133]. This phenomenon has been attributed to the effects 
of cholesterol on membrane fluidity and rigidity, where the activation energy associated 
with initiating and driving membrane-membrane fusion is lowest when these biophysical 
properties are most similar between the two fusing membranes and highest when these 
membrane biophysical properties are most different between the two fusing membranes. 
To date however, no direct experimental evidence has been presented to suggest that such 
a cholesterol-related membrane fusion phenomenon either occurs or is physiologically 
relevant to membrane-membrane fusion events in living cells. 
 If this novel model predicting membrane fusion efficiency is extended to 
membrane-membrane fusion events known to occur in skeletal muscle, especially those 
involved in insulin-stimulated GLUT4 translocation and subsequent fusion of GLUT4-
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containing GSV membranes with the sarcolemma/T-tubule membrane, several 
predictions can be made. The first is that any difference in relative cholesterol content 
between sarcolemma/T-Tubule and GLUT4-containing GSV vesicle membranes will 
result in inhibition of insulin stimulated glucose uptake. The second is that the greater the 
difference is in relative cholesterol content between sarcolemma/T-Tubule and GLUT4-
containing GSV vesicle membranes, the greater the resulting inhibition of insulin 
stimulated glucose uptake.  The third is that conditions which result in equal cholesterol 
enrichment of both the sarcoplasmic/T-tubule and the GSV membranes equally will 
result in less or potentially no inhibition of insulin stimulated glucose uptake compared to 
those conditions which result in differential membrane cholesterol enrichment.    
 If this putative model of physiologically relevant membrane-membrane fusion 
events is correct, then experimental evidence generated in the current study of insulin 
stimulated glucose uptake in C2C12 myotubes selectively enriched with cholesterol 
should support these predictions. Since GSV membranes consist of membrane 
components that bud off from the sarcoplasmic reticulum membrane, selective 
enrichment of the SR membrane will by extension result in increased GSV membrane 
cholesterol content. When the relative cholesterol content of sarcolemma/T-tubule 
membranes and sarcoplasmic reticulum/GSV membranes created using the various 
selective cholesterol enrichment conditions utilized in this study are examined the 
following observations can be made: 
 
1) Insulin stimulated glucose uptake is inhibited in those enrichment conditions 
where there is a difference in the cholesterol content of sarcolemma/T-tubule 
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membranes and sarcoplasmic reticulum/GSV membranes relative to one another, 
namely the 4hr Pulse, 4hr Pulse-4hr MβC, the 4hr Pulse-16hr Chase-4hr MβC and 
the 4hr Pulse-16hr Chase conditions. 
2) The enrichment condition exhibiting the greatest differential in membrane 
cholesterol content (i.e. 4hr Pulse) is the condition exhibiting the greatest 
inhibition of insulin stimulated glucose uptake (i.e. 4hr Pulse), while the 
enrichment condition exhibiting the next greatest differential membrane 
cholesterol content (i.e. 4hr Pulse-16hr Chase-4hr MβC) is the condition 
exhibiting the next greatest inhibition of insulin stimulated glucose uptake.  
3) The enrichment condition exhibiting the greatest amount of membrane 
cholesterol overall but having the most equal membrane cholesterol content of the 
enrichment conditions (i.e. 4hr Pulse-16hr Chase-4hr Pulse) is not the condition 
exhibiting the greatest inhibition of insulin stimulated glucose uptake. 
 
As such, the experimental observations listed above support the predictions of a novel 
model of membrane-membrane fusion events as it relates to insulin stimulated glucose 
uptake and cholesterol membrane enrichment in C2C12 myotubes. However, the 4hr 
Pulse-16h Chase enrichment condition does not appear to fit all aspects of this model. For 
example, the 4hr Pulse-16h Chase enrichment condition was shown to selectively enrich 
the sarcoplasmic membrane/GSV membrane but does appear to exhibit inhibition of 
insulin stimulated glucose uptake, rather it results in a rightward-shift in the insulin dose 
response curve. It remains unclear as to the exact cellular mechanism(s) that may explain 
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the development of myotube insensitivity to insulin under these cholesterol enrichment 
conditions, but it is possible that it may also be related to reduced GSV membrane fusion. 
 
CONCLUSION 
The present study has developed and characterized a reproducible tissue culture model of 
skeletal muscle myofibers in vivo consisting of terminally differentiated C2C12 myotubes 
in which to mechanistically investigate the cellular mechanisms involved in insulin-
stimulated glucose uptake quantified using a fluorescent analog of glucose, 2-NBDG. In 
turn, this differentiated C2C12 myotube model was then be used to investigate the effects 
of selective cholesterol enrichment of specific myotube membranes on insulin signaling 
and insulin-stimulated glucose uptake. 
Using this in vitro C2C12 myotube model, we show insulin stimulated glucose 
uptake across a range of different insulin concentrations and describe what appears to be 
the initiation of a rapid negative feedback loop on the insulin signaling pathway 
associated with acute exposure to high concentrations of insulin that results in inhibition 
of insulin stimulated glucose uptake. Further, we demonstrate that pulse-chase labeling 
protocols developed as part of this study can selectively enrich sarcolemma/T-tubule and 
sarcoplasmic reticulum membranes with cholesterol in a defined, mechanistic fashion.  In 
turn we show that inhibition of insulin-stimulated glucose uptake in C2C12 myotubes is 
causally linked to increased membrane cholesterol content and suggest a novel model for 
how and why differential membrane cholesterol content negatively effects membrane-
membrane fusion events required for GLUT4-containing GSV membrane fusion with the 
sarcolemma/T-tubule membrane during insulin stimulated glucose uptake. These data 
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provide strong evidence that increased cholesterol content located in specific membranes 
of skeletal muscle are not only associated with but directly contribute with the 
development of insulin resistance. Finally, this study also provides evidence to support a 
mechanistic model capable of explaining the underlying relationship between conditions 
exhibiting abnormal regulation of lipid metabolism and increased circulating cholesterol 
levels, such as obesity and hypercholesterolemia, and the onset of insulin insensitivity 
and glucose tolerance in conditions such as metabolic syndrome and Type 2 diabetes. 
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